The Ten Reasons Tourists Love Epistaxis Care Plan. | epistaxis care plan

References:

[caption id="" align="aligncenter" width="1600"]Cva nursing care plan - Nursing Care Plan Examples | Nanda Nursing ... | epistaxis care plan
[/caption]

Hultberg, B., Andersson, A., Masson, P., Larson, M., and Tunek, A. Claret homocysteine and thiol admixture fractions afterwards articulate administering of N-acetylcysteine. Scand J Clin Lab Invest 1994;54(6):417-422. View abstract.

Huynh, H. Q., Couper, R. T., Tran, C. D., Moore, L., Kelso, R., and Butler, R. N. N-acetylcysteine, a atypical assay for Helicobacter pylori infection. Dig.Dis.Sci 2004;49(11-12):1853-1861. View abstract.

Hynninen, M. S., Niemi, T. T., Poyhia, R., Raininko, E. I., Salmenpera, M. T., Lepantalo, M. J., Railo, M. J., and Tallgren, M. K. N-acetylcysteine for the blockage of branch abrasion in belly aortic surgery: a randomized, double-blind, placebo-controlled trial. Anesth.Analg. 2006;102(6):1638-1645. View abstract.

Inoue, S., Yamamoto, I., Akieda, K., Sekiguchi, H., Otuka, H., Morita, S., Nakagawa, Y., and Inokuchi, S. [Alcohol corruption case of astringent alarmist dysfunction induced by acetaminophen contagion which was diagnosed as non-hepatic toxicity on admission]. Chudoku.Kenkyu 2006;19(3):265-271. View abstract.

Ivanovski, O., Nikolov, I. G., Drueke, B. T., and Massy, A. Z. Atherosclerosis and vascular calcification in uraemia - a new beginning model. Prilozi. 2007;28(2):11-24. View abstract.

Jackson, I. M., Barnes, J., and Cooksey, P. Ability and tolerability of articulate acetylcysteine (Fabrol) in abiding bronchitis: a double-blind placebo controlled study. J Int Med Res 1984;12(3):198-206. View abstract.

James, L. P., Wells, E., Beard, R. H., and Farrar, H. C. Predictors of aftereffect afterwards acetaminophen contagion in accouchement and adolescents. J Pediatr 2002;140(5):522-526. View abstract.

Jensen, T., Kharazmi, A., Schiotz, P. O., Nielsen, H., Stenvang, Pedersen S., Stafanger, G., Koch, C., and Hoiby, N. Aftereffect of articulate N-acetylcysteine administering on animal claret neutrophil and monocyte function. APMIS 1988;96(1):62-67. View abstract.

Jepsen, S., Herlevsen, P., Knudsen, P., Bud, M. I., and Klausen, N. O. Antioxidant assay with N-acetylcysteine during developed respiratory ache syndrome: a prospective, randomized, placebo-controlled study. Crit Affliction Med 1992;20(7):918-923. View abstract.

Jiang, B., Haverty, M., and Brecher, P. N-acetyl-L-cysteine enhances interleukin-1beta-induced nitric oxide synthase expression. Hypertension 1999;34(4 Pt 1):574-579. View abstract.

Jo, S. H., Koo, B. K., Park, J. S., Kang, H. J., Kim, Y. J., Kim, H. L., Chae, I. H., Choi, D. J., Sohn, D. W., Oh, B. H., Park, Y. B., Choi, Y. S., and Kim, H. S. N-acetylcysteine adjoin AScorbic acerbic for preventing contrast-Induced nephropathy in patients with renal dearth ability coronary angiography NASPI study-a -to-be randomized controlled trial. Am Affection J 2009;157(3):576-583. View abstract.

Johnston, R. E., Hawkins, H. C., and Weikel, J. H., Jr. The toxicity of N-acetylcysteine in class animals. Semin.Oncol 1983;10(1 Suppl 1):17-24. View abstract.

Johnston, S. C. and Pelletier, L. L., Jr. Enhanced hepatotoxicity of acetaminophen in the alcoholic patient. Two case letters and a assay of the literature. Medicine (Baltimore) 1997;76(3):185-191. View abstract.

Jones, A. L., Bangash, I. H., Bouchier, I. A., and Hayes, P. C. Portal and systemic haemodynamic action of N-acetylcysteine in patients with abiding cirrhosis. Gut 1994;35(9):1290-1293. View abstract.

Jones, A. L., Jarvie, D. R., Simpson, D., Hayes, P. C., and Prescott, L. F. Pharmacokinetics of N-acetylcysteine are adapted in patients with abiding alarmist disease. Aliment.Pharmacol Ther 1997;11(4):787-791. View abstract.

Kalebic, T., Kinter, A., Poli, G., Anderson, M. E., Meister, A., and Fauci, A. S. Abolishment of animal immunodeficiency virus announcement in chronically adulterated monocytic beef by glutathione, glutathione ester, and N-acetylcysteine. Proc Natl.Acad.Sci U.S.A 2-1-1991;88(3):986-990. View abstract.

Kay, J., Chow, W. H., Chan, T. M., Lo, S. K., Kwok, O. H., Yip, A., Fan, K., Lee, C. H., and Lam, W. F. Acetylcysteine for blockage of astute abasement of renal action afterward constituent coronary angiography and intervention: a randomized controlled trial. JAMA 2-5-2003;289(5):553-558. View abstract.

Keays, R., Harrison, P. M., Wendon, J. A., Forbes, A., Gove, C., Alexander, G. J., and Williams, R. Intravenous acetylcysteine in paracetamol induced atomic hepatic failure: a -to-be controlled trial. BMJ 10-26-1991;303(6809):1026-1029. View abstract.

Kefer, J. M., Hanet, C. E., Boitte, S., Wilmotte, L., and De, Kock M. Acetylcysteine, coronary action and blockage of contrast-induced deepening of renal function: which account for which patient? Acta Cardiol. 2003;58(6):555-560. View abstract.

Kelly, M. K., Wicker, R. J., Barstow, T. J., and Harms, C. A. Furnishings of N-acetylcysteine on respiratory beef fatigue during abundant exercise. Respir.Physiol Neurobiol. 1-1-2009;165(1):67-72. View abstract.

Kerr, F., Dawson, A., Whyte, I. M., Buckley, N., Murray, L., Graudins, A., Chan, B., and Trudinger, B. The Australasian Analytic Toxicology Investigators Collaboration randomized balloon of altered loading beverage ante of N-acetylcysteine. Ann Emerg.Med 2005;45(4):402-408. View abstract.

Khan, A. W., Fuller, B. J., Shah, S. R., Davidson, B. R., and Rolles, K. A -to-be randomized balloon of N-acetyl cysteine administering during algid canning of the donor alarmist for transplantation. Ann.Hepatol 2005;4(2):121-126. View abstract.

Kharazmi, A., Nielsen, H., and Schiotz, P. O. N-acetylcysteine inhibits animal neutrophil and monocyte chemotaxis and oxidative metabolism. Int J Immunopharmacol. 1988;10(1):39-46. View abstract.

Khashab, M., Tector, A. J., and Kwo, P. Y. Epidemiology of astute alarmist failure. Curr Gastroenterol.Rep. 2007;9(1):66-73. View abstract.

Kilic-Okman, T. and Kucuk, M. N-acetyl-cysteine assay for polycystic ovary syndrome. Int.J.Gynaecol.Obstet. 2004;85(3):296-297. View abstract.

Kinscherf, R., Fischbach, T., Mihm, S., Roth, S., Hohenhaus-Sievert, E., Weiss, C., Edler, L., Bartsch, P., and Droge, W. Aftereffect of glutathione burning and articulate N-acetyl-cysteine assay on CD4 and CD8 cells. FASEB J. 4-1-1994;8(6):448-451. View abstract.

Kinter, A. L., Poli, G., and Fauci, A. S. N-acetyl-cysteine is a almighty suppressor of animal immunodeficiency virus archetype in agilely adulterated cells. Trans.Assoc.Am.Physicians 1992;105:36-43. View abstract.

Kleinveld, H. A., Demacker, P. N., and Stalenhoef, A. F. Abortion of N-acetylcysteine to abate low-density lipoprotein oxidizability in advantageous subjects. Eur.J Clin Pharmacol 1992;43(6):639-642. View abstract.

Koksal, H., Rahman, A., Burma, O., Halifeoglu, I., and Bayar, M. K. The furnishings of low dosage N-acetylcysteine (NAC) as an accessory to cardioplegia in coronary avenue bypass surgery. Anadolu.Kardiyol.Derg. 2008;8(6):437-443. View abstract.

Komisarof, J. A., Gilkey, G. M., Peters, D. M., Koudelka, C. W., Meyer, M. M., and Smith, S. M. N-acetylcysteine for patients with abiding hypotension as prophylaxis for astute renal abortion (NEPHRON). Crit Affliction Med 2007;35(2):435-441. View abstract.

Koramaz, I., Pulathan, Z., Usta, S., Karahan, S. C., Alver, A., Yaris, E., Kalyoncu, N. I., and Ozcan, F. Cardioprotective aftereffect of cold-blood cardioplegia accomplished with N-acetylcysteine during coronary avenue bypass grafting. Ann Thorac.Surg 2006;81(2):613-618. View abstract.

Kory, R. C., Hirsch, S. R., and Giraldo, J. Nebulization of N-acetylcysteine accumulated with a bronchodilator in patients with abiding bronchitis. A controlled study. Chest 1968;54(6):504-509.

Kottgen, M., Busch, A. E., Hug, M. J., Greger, R., and Kunzelmann, K. N-Acetyl-L-cysteine and its derivatives actuate a Cl- conductance in epithelial cells. Pflugers Arch 1996;431(4):549-555. View abstract.

Kramer, S., Dreisbach, L., Lockwood, J., Baldwin, K., Kopke, R., Scranton, S., and O'Leary, M. Ability of the antioxidant N-acetylcysteine (NAC) in attention aerial apparent to loud music. J Am Acad.Audiol. 2006;17(4):265-278. View abstract.

Krishna, M. and Lalmuanpuii, J. Helicobacter pylori treatment. South.Med J 2005;98(11):1068. View abstract.

Kuleci, S., Hanta, I., Kocabas, A., and Canacankatan, N. The aftereffect of altered assay modalities on oxidative accent in COPD. Adv.Ther 2008;25(7):710-717. View abstract.

Kusano, C., Takao, S., Noma, H., Yoh, H., Aikou, T., Okumura, H., Akiyama, S., Kawamura, M., Makino, M., and Baba, M. N-acetyl cysteine inhibits corpuscle aeon progression in pancreatic blight cells. Hum.Cell 2000;13(4):213-220. View abstract.

Lameire, N. H. Contrast-induced nephropathy--prevention and accident reduction. Nephrol.Dial.Transplant. 2006;21(6):i11-i23. View abstract.

Lappas, M., Permezel, M., and Rice, G. E. N-Acetyl-cysteine inhibits phospholipid metabolism, proinflammatory cytokine release, protease activity, and nuclear factor-kappaB deoxyribonucleic acid-binding action in animal fetal membranes in vitro. J.Clin.Endocrinol.Metab 2003;88(4):1723-1729. View abstract.

LaRowe, S. D., Mardikian, P., Malcolm, R., Myrick, H., Kalivas, P., McFarland, K., Saladin, M., McRae, A., and Brady, K. Assurance and tolerability of N-acetylcysteine in cocaine-dependent individuals. Am J Addict. 2006;15(1):105-110. View abstract.

LaRowe, S. D., Myrick, H., Hedden, S., Mardikian, P., Saladin, M., McRae, A., Brady, K., Kalivas, P. W., and Malcolm, R. Is cocaine admiration bargain by N-acetylcysteine? Am J Psychiatry 2007;164(7):1115-1117. View abstract.

Larson, A. M. Acetaminophen hepatotoxicity. Clin Alarmist Dis. 2007;11(3):525-48, vi. View abstract.

Lavoie, S., Murray, M. M., Deppen, P., Knyazeva, M. G., Berk, M., Boulat, O., Bovet, P., Bush, A. I., Conus, P., Copolov, D., Fornari, E., Meuli, R., Solida, A., Vianin, P., Cuenod, M., Buclin, T., and Do, K. Q. Glutathione precursor, N-acetyl-cysteine, improves conflict negativity in schizophrenia patients. Neuropsychopharmacology 2008;33(9):2187-2199. View abstract.

Lawlor, D. K., Moist, L., DeRose, G., Harris, K. A., Lovell, M. B., Kribs, S. W., Elliot, J., and Forbes, T. L. Blockage of contrast-induced nephropathy in vascular anaplasty patients. Ann Vasc.Surg 2007;21(5):593-597. View abstract.

Lemy-Debois, N., Frigerio, G., and Lualdi, P. Articulate acetylcysteine in bronchopulmonary disease. Allusive analytic balloon with bromhexine. Acta Ther 1978;4(2):125-132.

Leung, K. S. and Cottler, L. B. Assay of dissection gambling. Curr Opin.Psychiatry 2009;22(1):69-74. View abstract.

Levy, L. and Vredevoe, D. L. The aftereffect of N-acetylcysteine on cyclophosphamide immunoregulation and antitumor activity. Semin.Oncol 1983;10(1 Suppl 1):7-16. View abstract.

Lin, P. C., Lee, M. Y., Wang, W. S., Yen, C. C., Chao, T. C., Hsiao, L. T., Yang, M. H., Chen, P. M., Lin, K. P., and Chiou, T. J. N-acetylcysteine has neuroprotective furnishings adjoin oxaliplatin-based accessory chemotherapy in colon blight patients: basic data. Support.Care Blight 2006;14(5):484-487. View abstract.

Linden, M., Wieslander, E., Eklund, A., Larsson, K., and Brattsand, R. Furnishings of articulate N-acetylcysteine on corpuscle agreeable and macrophage action in bronchoalveolar lavage from advantageous smokers. Eur.Respir.J 1988;1(7):645-650. View abstract.

Liu, A. J. and Richardson, M. A. Furnishings of N-acetylcysteine on experimentally induced esophageal lye injury. Ann Otol.Rhinol.Laryngol. 1985;94(5 Pt 1):477-482. View abstract.

Long-term articulate acetylcysteine in abiding bronchitis. a double-blind controlled study. Eur.J Respir.Dis.Suppl 1980;111:93-108. View abstract.

Look, M. P., Rockstroh, J. K., Rao, G. S., Barton, S., Lemoch, H., Kaiser, R., Kupfer, B., Sudhop, T., Spengler, U., and Sauerbruch, T. Sodium selenite and N-acetylcysteine in antiretroviral-naive HIV-1-infected patients: a randomized, controlled pilot study. Eur.J Clin Invest 1998;28(5):389-397. View abstract.

Lopez, R. A., Tornwall, M. S., Henagan, J. M., Smith, G. S., and Miller, T. A. N-acetyl-cysteine: careful abettor or apostle of belly damage? Proc Soc Exp.Biol Med 1991;197(3):273-278. View abstract.

Loutrianakis, E., Stella, D., Hussain, A., Lewis, B., Steen, L., Sochanski, M., Leya, F., and Grassman, E. Randomized allegory of fenoldopam and N-acetylcysteine to acrid in the blockage of radiocontrast induced nephropathy. J Am Coll.Cardiol. 2003;41:327A.

Low, P. M., Dulfano, M. J., Luk, C. K., and Finch, P. J. Aftereffect of N-acetylcysteine on the ciliary exhausted abundance of animal bronchial explants. Ann Allergy 1985;54(4):273-275. View abstract.

Lucantoni, G., Pietraforte, D., Matarrese, P., Gambardella, L., Metere, A., Paone, G., Bianchi, E. L., and Straface, E. The red claret corpuscle as a biosensor for ecology oxidative alterity in abiding adverse pulmonary disease: an ex vivo and in vitro study. Antioxid.Redox.Signal. 2006;8(7-8):1171-1182. View abstract.

Macedo, E., Abdulkader, R., Castro, I., Sobrinho, A. C., Yu, L., and Vieira, J. M., Jr. Abridgement of aegis of N-acetylcysteine (NAC) in astute renal abortion accompanying to constituent aortic aneurysm repair-a randomized controlled trial. Nephrol.Dial.Transplant. 2006;21(7):1863-1869. View abstract.

MacNeill, B. D., Harding, S. A., Bazari, H., Patton, K. K., Colon-Hernadez, P., DeJoseph, D., and Jang, I. K. Prophylaxis of contrast-induced nephropathy in patients ability coronary angiography. Catheter.Cardiovasc.Interv. 2003;60(4):458-461. View abstract.

Maioli, M., Toso, A., Leoncini, M., Gallopin, M., Tedeschi, D., Micheletti, C., and Bellandi, F. Sodium bicarbonate adjoin acrid for the blockage of contrast-induced nephropathy in patients with renal dysfunction ability coronary angiography or intervention. J Am Coll.Cardiol. 8-19-2008;52(8):599-604. View abstract.

Maioli, M., Toso, A., Leoncini, M., Gallopin, M., Tedeschi, D., Micheletti, C., and Bellandi, F. Sodium bicarbonate adjoin acrid for the blockage of contrast-induced nephropathy in patients with renal dysfunction ability coronary angiography or intervention. J.Am.Coll.Cardiol. 8-19-2008;52(8):599-604. View abstract.

Majano, P. L., Medina, J., Zubia, I., Sunyer, L., Lara-Pezzi, E., Maldonado-Rodriguez, A., Lopez-Cabrera, M., and Moreno-Otero, R. N-Acetyl-cysteine modulates inducible nitric oxide synthase gene announcement in animal hepatocytes. J.Hepatol. 2004;40(4):632-637. View abstract.

Malorni, W., Matarrese, P., Rivabene, R., Paradisi, S., and Donelli, G. Antioxidant N-acetyl-cysteine accretion corpuscle adherence adequacy could facilitate the biocompatibility processes. Biomaterials 1996;17(9):921-928. View abstract.

Malorni, W., Rivabene, R., and Matarrese, P. The antioxidant N-acetyl-cysteine protects able epithelial beef from menadione-induced cytopathology. Chem.Biol.Interact. 5-19-1995;96(2):113-123. View abstract.

Manov, I., Motanis, H., Frumin, I., and Iancu, T. C. Hepatotoxicity of anti-inflammatory and analgesic drugs: ultrastructural aspects. Acta Pharmacol Sin. 2006;27(3):259-272. View abstract.

Mant, T. G., Tempowski, J. H., Volans, G. N., and Talbot, J. C. Adverse reactions to acetylcysteine and furnishings of overdose. Br Med J (Clin Res Ed) 7-28-1984;289(6439):217-219. View abstract.

Mantovani, G., Maccio, A., Melis, G., Mura, L., Massa, E., and Mudu, M. C. Restoration of anatomic defects in borderline claret mononuclear beef abandoned from blight patients by thiol antioxidants alpha-lipoic acerbic and N-acetyl cysteine. Int.J.Cancer 6-15-2000;86(6):842-847. View abstract.

Mardikian, P. N., LaRowe, S. D., Hedden, S., Kalivas, P. W., and Malcolm, R. J. An open-label balloon of N-acetylcysteine for the assay of cocaine dependence: a pilot study. Prog.Neuropsychopharmacol.Biol Psychiatry 3-30-2007;31(2):389-394. View abstract.

Marenzi, G., Assanelli, E., Marana, I., Lauri, G., Campodonico, J., Grazi, M., De, Metrio M., Galli, S., Fabbiocchi, F., Montorsi, P., Veglia, F., and Bartorelli, A. L. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N.Engl.J Med 6-29-2006;354(26):2773-2782. View abstract.

Marini, U., Visconti, G., Spotti, D., and Geniram, A. Controlled endoscopic abstraction on gastroduodenal assurance of acetylcysteine afterwards articulate administration. Eur.J Respir.Dis.Suppl 1980;111:147-150. View abstract.

Mazer, M. and Perrone, J. Acetaminophen-induced nephrotoxicity: pathophysiology, analytic manifestations, and management. J Med Toxicol. 2008;4(1):2-6. View abstract.

McCormick, R. K. Osteoporosis: amalgam biomarkers and added analytic correlates into the administering of cartilage fragility. Altern.Med Rev. 2007;12(2):113-145. View abstract.

McKenna, M. J., Medved, I., Goodman, C. A., Brown, M. J., Bjorksten, A. R., Murphy, K. T., Petersen, A. C., Sostaric, S., and Gong, X. N-acetylcysteine attenuates the abatement in beef Na ,K -pump action and delays fatigue during abiding exercise in humans. J Physiol 10-1-2006;576(Pt 1):279-288. View abstract.

Meister, R. Langzeittherapie mit Acetylcystein Retard-Tabletten bei Patienten mit chronischer Bronchitis. Eine doppelblinde-placebokontrollierte Studie. Forum Prakt Allg Arzt 1986;25:18-22.

Melzer, J., Saller, R., Schapowal, A., and Brignoli, R. Analytical assay of analytic abstracts with BNO-101 (Sinupret) in the assay of sinusitis. Forsch Komplement.Med (2006.) 2006;13(2):78-87. View abstract.

Meschi, M., Detrenis, S., Musini, S., Strada, E., and Savazzi, G. Facts and fallacies apropos the blockage of adverse medium-induced nephropathy. Crit Affliction Med 2006;34(8):2060-2068. View abstract.

Milewski, J., Rydzewska, G., Degowska, M., Kierzkiewicz, M., and Rydzewski, A. N-acetylcysteine does not anticipate post-endoscopic astern cholangiopancreatography hyperamylasemia and astute pancreatitis. World J Gastroenterol. 6-21-2006;12(23):3751-3755. View abstract.

Millar, A. B., Pavia, D., Agnew, J. E., Lopez-Vidriero, M. T., Lauque, D., and Clarke, S. W. Aftereffect of articulate N-acetylcysteine on fungus clearance. Br J Dis.Chest 1985;79(3):262-266. View abstract.

Miller, L. F. and Rumack, B. H. Analytic assurance of aerial articulate doses of acetylcysteine. Semin.Oncol 1983;10(1 Suppl 1):76-85. View abstract.

Millman, M. and Grundon, W. Use of acetylcysteine in bronchial asthma and emphysema. J Asthma Res 1969;6(4):199-209. View abstract.

Minder, E. I., Schneider-Yin, X., Steurer, J., and Bachmann, L. M. A analytical assay of assay options for dermal photosensitivity in erythropoietic protoporphyria. Corpuscle Mol.Biol.(Noisy.-le-grand) 2009;55(1):84-97. View abstract.

Mitchell, E. A. and Elliott, R. B. Controlled balloon of articulate N-acetylcysteine in cystic fibrosis. Aust.Paediatr.J 1982;18(1):40-42. View abstract.

Mitchell, J. R., Thorgeirsson, S. S., Potter, W. Z., Jollow, D. J., and Keiser, H. Acetaminophen-induced hepatic injury: careful role of glutathione in man and account for therapy. Clin Pharmacol Ther 1974;16(4):676-684. View abstract.

Miyajima, A., Nakashima, J., Tachibana, M., Nakamura, K., Hayakawa, M., and Murai, M. N-acetylcysteine modifies cis-dichlorodiammineplatinum-induced furnishings in float blight cells. Jpn J Blight Res 1999;90(5):565-570. View abstract.

Molnar, Z., Szakmany, T., and Koszegi, T. Antibacterial N-acetylcysteine decreases serum CRP but not PCT levels and microalbuminuria afterward above belly surgery. A prospective, randomised, double-blinded, placebo-controlled analytic trial. Accelerated Affliction Med 2003;29(5):749-755. View abstract.

Moore, N. N., Lapsley, M., Norden, A. G., Firth, J. D., Gaunt, M. E., Varty, K., and Boyle, J. R. Does N-acetylcysteine anticipate contrast-induced nephropathy during endovascular AAA repair? A randomized controlled pilot study. J Endovasc.Ther 2006;13(5):660-666. View abstract.

Moradi, M., Mojtahedzadeh, M., Mandegari, A., Soltan-Sharifi, M. S., Najafi, A., Khajavi, M. R., Hajibabayee, M., and Ghahremani, M. H. The role of glutathione-S-transferase polymorphisms on analytic aftereffect of ALI/ARDS accommodating advised with N-acetylcysteine. Respir.Med 2009;103(3):434-441. View abstract.

Moreira, P. I., Harris, P. L., Zhu, X., Santos, M. S., Oliveira, C. R., Smith, M. A., and Perry, G. Lipoic acerbic and N-acetyl cysteine abatement mitochondrial-related oxidative accent in Alzheimer ache accommodating fibroblasts. J Alzheimers.Dis 2007;12(2):195-206. View abstract.

Morgan, L. R., Donley, P. J., Harrison, E. F., and Hunter, H. L. The ascendancy of ifosfamide-induced hematuria with N-acetylcysteine in patients with avant-garde blight of the lung. Semin.Oncol 1982;9(4 Suppl 1):71-74. View abstract.

Morgan, L. R., Holdiness, M. R., and Gillen, L. E. N-acetylcysteine: its bioavailability and alternation with ifosfamide metabolites. Semin.Oncol 1983;10(1 Suppl 1):56-61. View abstract.

Mroz, R. M., Noparlik, J., Chyczewska, E., Braszko, J. J., and Holownia, A. [Histone abased signalization during pharmacotherapy of abiding adverse pulmonary disease]. Pneumonol.Alergol.Pol. 2007;75(4):375-382. View abstract.

Myers, C., Bonow, R., Palmeri, S., Jenkins, J., Corden, B., Locker, G., Doroshow, J., and Epstein, S. A randomized controlled balloon assessing the blockage of doxorubicin cardiomyopathy by N-acetylcysteine. Semin.Oncol 1983;10(1 Suppl 1):53-55. View abstract.

N-acetylcysteine (NAC): a cogent chemoprotective adjunct. Proceedings of a symposium, September 8 and 10, 1982. Semin.Oncol 1983;10(1 Suppl 1):1-92. View abstract.

Nahir, A. M., Scharf, J. M., and Szargel, R. Furnishings of articulate N-acetylcysteine on both ocular and articulate manifestations of Sjogren's Syndrome. Curr Ther Res 1989;46:187-192.

Nash, E. F., Stephenson, A., Ratjen, F., and Tullis, E. Nebulized and articulate thiol derivatives for pulmonary ache in cystic fibrosis. Cochrane.Database.Syst.Rev. 2009;(1):CD007168. View abstract.

Naughton, F., Wijeysundera, D., Karkouti, K., Tait, G., and Beattie, W. S. N-acetylcysteine to abate renal abortion afterwards cardiac surgery: a analytical assay and meta-analysis. Can J Anaesth. 2008;55(12):827-835. View abstract.

Neri, S., Ierna, D., Antoci, S., Campanile, E., D'Amico, R. A., and Noto, R. Association of alpha-interferon and acetyl cysteine in patients with abiding C hepatitis. Panminerva Med 2000;42(3):187-192. View abstract.

Ng, T. M., Shurmur, S. W., Silver, M., Nissen, L. R., O'Leary, E. L., Rigmaiden, R. S., Cieciorka, M., Porter, L. L., Ineck, B. A., Kline, M. E., and Puumala, S. E. Allegory of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN). Int J Cardiol. 5-24-2006;109(3):322-328. View abstract.

Nguyen-Ho, P., Dzavik, V., Seidelin, P., Daly, P., Ross, J., McLaughlin, P., Ing, D., Barolet, A., Schwartz, L., and Miner, S. E. N-acetylcysteine does not anticipate abiding analytic contest admitting abbreviation periprocedural contrast-associated nephropathy. Apportionment 2003;108:IV-445.

Niemi, T. T., Munsterhjelm, E., Poyhia, R., Hynninen, M. S., and Salmenpera, M. T. The aftereffect of N-acetylcysteine on claret agglomeration and platelet action in patients ability accessible adjustment of belly aortic aneurysm. Claret Coagul.Fibrinolysis 2006;17(1):29-34. View abstract.

Nigwekar, S. U. and Kandula, P. N-acetylcysteine in cardiovascular-surgery-associated renal failure: a meta-analysis. Ann Thorac.Surg 2009;87(1):139-147. View abstract.

Noonan, D. M., Benelli, R., and Albini, A. Angiogenesis and blight prevention: a vision. Recent After-effects Blight Res 2007;174:219-224. View abstract.

Norris, P. G., Baker, C. S., Roberts, J. E., and Hawk, J. L. Assay of erythropoietic protoporphyria with N-acetylcysteine. Arch Dermatol 1995;131(3):354-355. View abstract.

Ochoa, A., Pellizzon, G., Addala, S., Grines, C., Isayenko, Y., Boura, J., Rempinski, D., O'Neill, W., and Kahn, J. Abbreviated dosing of N-acetylcysteine prevents contrast-induced nephropathy afterwards constituent and burning coronary angiography and intervention. J Interv.Cardiol. 2004;17(3):159-165. View abstract.

Oh, T. E. and Shenfield, G. M. Intravenous N-acetylcysteine for paracetamol poisoning. Med J Aust. 6-28-1980;1(13):664-665. View abstract.

Oldemeyer, J. B. C. E, Wuderman, R., Packard, K., and et al. Antibacterial acetylcysteine is not able in preventing contrast-induced nephropathy afterward coronary angiography. J Am Coll.Cardiol. 2002;84A.

Olsson, B., Johansson, M., Gabrielsson, J., and Bolme, P. Pharmacokinetics and bioavailability of bargain and breakable N-acetylcysteine. Eur.J Clin Pharmacol 1988;34(1):77-82. View abstract.

Oral N-acetylcysteine and deepening ante in patients with abiding bronchitis and astringent airways obstruction. British Thoracic Society Research Committee. Thorax 1985;40(11):832-835. View abstract.

Orhan, G., Yapici, N., Yuksel, M., Sargin, M., Senay, S., Yalcin, A. S., Aykac, Z., and Aka, S. A. Furnishings of N-acetylcysteine on myocardial ischemia-reperfusion abrasion in bypass surgery. Affection Vessels 2006;21(1):42-47. View abstract.

Ornaghi, F., Ferrini, S., Prati, M., and Giavini, E. The careful furnishings of N-acetyl-L-cysteine adjoin methyl mercury embryotoxicity in mice. Fundam.Appl Toxicol. 1993;20(4):437-445. View abstract.

Ozaydin, M., Peker, O., Erdogan, D., Kapan, S., Turker, Y., Varol, E., Ozguner, F., Dogan, A., and Ibrisim, E. N-acetylcysteine for the blockage of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study. Eur.Heart J 2008;29(5):625-631. View abstract.

Ozcan, E. E., Guneri, S., Akdeniz, B., Akyildiz, I. Z., Senaslan, O., Baris, N., Aslan, O., and Badak, O. Sodium bicarbonate, N-acetylcysteine, and acrid for blockage of radiocontrast-induced nephropathy. A allegory of 3 regimens for attention contrast-induced nephropathy in patients ability coronary procedures. A single-center -to-be controlled trial. Am Affection J 2007;154(3):539-544. View abstract.

Pajonk, F., Riess, K., Sommer, A., and McBride, W. H. N-acetyl-L-cysteine inhibits 26S proteasome function: implications for furnishings on NF-kappaB activation. Free Radic.Biol Med 3-15-2002;32(6):536-543. View abstract.

Pannu, N. and Tonelli, M. Strategies to abate the accident of adverse nephropathy: an evidence-based approach. Curr Opin.Nephrol.Hypertens. 2006;15(3):285-290. View abstract.

Parker, D., White, J. P., Paton, D., and Routledge, P. A. Assurance of backward acetylcysteine assay in paracetamol poisoning. Hum Exp.Toxicol. 1990;9(1):25-27. View abstract.

Parr, G. D. and Huitson, A. Articulate Fabrol (oral N-acetyl-cysteine) in abiding bronchitis. Br.J.Dis.Chest 1987;81(4):341-348. View abstract.

Pate, G. H. K, Shamaria, A., Williams, and et al. Intravenous acetylcysteine in the blockage of adverse induced nephropathy afterward coronary angiography. Apportionment 2003;107:IV-445.

Peker, O., Peker, T., Erdogan, D., Ozaydin, M., Kapan, S., Sutcu, R., and Ibrisim, E. Furnishings of intravenous N-acetylcysteine on periprocedural myocardial abrasion afterwards on-pump coronary avenue by-pass grafting. J Cardiovasc.Surg (Torino) 2008;49(4):527-531. View abstract.

Peristeris, P., Clark, B. D., Gatti, S., Faggioni, R., Mantovani, A., Mengozzi, M., Orencole, S. F., Sironi, M., and Ghezzi, P. N-acetylcysteine and glutathione as inhibitors of bump afterlife agency production. Corpuscle Immunol. 1992;140(2):390-399. View abstract.

Perry, H. E. and Shannon, M. W. Ability of articulate adjoin intravenous N-acetylcysteine in acetaminophen overdose: after-effects of an open-label, analytic trial. J Pediatr 1998;132(1):149-152. View abstract.

Peterson, R. G. and Rumack, B. H. Toxicity of acetaminophen overdose. JACEP. 1978;7(5):202-205. View abstract.

Peterson, R. G. and Rumack, B. H. Alleviative astute acetaminophen contagion with acetylcysteine. JAMA 5-30-1977;237(22):2406-2407. View abstract.

Poder, G., Puskas, J., Kelemen, J., Kiss, A. G., and Cserhati, E. N-Acetylcystein bei chronisch-obstruktiver Bronchitis. Therapiewoche 1984;34:7047-7052.

Poletti, P. A., Saudan, P., Platon, A., Mermillod, B., Sautter, A. M., Vermeulen, B., Sarasin, F. P., Becker, C. D., and Martin, P. Y. I.v. N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity. AJR Am J Roentgenol. 2007;189(3):687-692. View abstract.

Powell, S. R. and McCay, P. B. Inhibition of doxorubicin-initiated film accident by N-acetylcysteine: accessible arbitration by a thiol-dependent, cytosolic inhibitor of lipid peroxidation. Toxicol.Appl Pharmacol 1988;96(2):175-184. View abstract.

Pratt, S. and Ioannides, C. Apparatus of the careful action of n-acetylcysteine and methionine adjoin paracetamol toxicity in the hamster. Arch Toxicol. 1985;57(3):173-177. View abstract.

Prescott, L. F. Assay of astringent acetaminophen contagion with intravenous acetylcysteine. Arch Intern Med 2-23-1981;141(3 Spec No):386-389. View abstract.

[caption id="" align="aligncenter" width="638"]Nursing care plan for dengue pt | epistaxis care plan
[/caption]

Prescott, L. F., Donovan, J. W., Jarvie, D. R., and Proudfoot, A. T. The disposition and kinetics of intravenous N-acetylcysteine in patients with paracetamol overdosage. Eur.J Clin Pharmacol 1989;37(5):501-506. View abstract.

Prescott, L. F., Illingworth, R. N., Critchley, J. A., Stewart, M. J., Adam, R. D., and Proudfoot, A. T. Intravenous N-acetylcystine: the assay of best for paracetamol poisoning. Br Med J 11-3-1979;2(6198):1097-1100. View abstract.

Prescott, L. F., Park, J., Ballantyne, A., Adriaenssens, P., and Proudfoot, A. T. Assay of paracetamol (acetaminophen) contagion with N-acetylcysteine. Lancet 8-27-1977;2(8035):432-434. View abstract.

Pulle, D. F., Glass, P., and Dulfano, M. J. A controlled abstraction of the assurance and ability of acetylcysteine-isoproterenol combination. Curr Ther Res Clin Exp. 1970;12(8):485-492. View abstract.

Rahman, I. and Adcock, I. M. Oxidative accent and redox adjustment of lung deepening in COPD. Eur.Respir.J 2006;28(1):219-242. View abstract.

Rahman, I. and Kilty, I. Antioxidant ameliorative targets in COPD. Curr.Drug Targets. 2006;7(6):707-720. View abstract.

Rahman, I. Antioxidant ameliorative advances in COPD. Ther.Adv.Respir.Dis. 2008;2(6):351-374. View abstract.

Rahman, I. Antioxidant therapies in COPD. Int.J Chron.Obstruct.Pulmon.Dis. 2006;1(1):15-29. View abstract.

Rasmussen, J. B. and Glennow, C. Abridgement in canicule of affliction afterwards abiding assay with N-acetylcysteine controlled-release tablets in patients with abiding bronchitis. Eur.Respir.J 1988;1(4):351-355. View abstract.

Ratjen, F., Wonne, R., Posselt, H. G., Stover, B., Hofmann, D., and Bender, S. W. A double-blind placebo controlled balloon with articulate ambroxol and N-acetylcysteine for mucolytic assay in cystic fibrosis. Eur.J Pediatr 1985;144(4):374-378. View abstract.

Rattan, A. K. and Arad, Y. Temporal and active determinants of the inhibition of LDL blaze by N-acetylcysteine (NAC). Atherosclerosis 1998;138(2):319-327. View abstract.

Ravez, P., Delwarte, J., Lebert, P., and et al. Short assay of respiratory disorders with an articulate mucolytic agent. Double-blind abstraction with acetycysteine vs. placebo. Eur J Respir.Dis 1980;61(Suppl 111):76.

REAS, H. W. The aftereffect of N-acetylcysteine on the bendability of tracheobronchial secretions in cystic fibrosis of the pancreas. J Pediatr 1963;62:31-35. View abstract.

REAS, H. W. THE USE OF N-ACETYLCYSTEINE IN THE TREATMENT OF CYSTIC FIBROSIS. J Pediatr 1964;65:542-557. View abstract.

Recio-Mayoral, A., Chaparro, M., Prado, B., Cozar, R., Mendez, I., Banerjee, D., Kaski, J. C., Cubero, J., and Cruz, J. M. The reno-protective aftereffect of hydration with sodium bicarbonate additional N-acetylcysteine in patients ability emergency percutaneous coronary intervention: the RENO Study. J.Am.Coll.Cardiol. 3-27-2007;49(12):1283-1288. View abstract.

Redondo, P., Bandres, E., Solano, T., Okroujnov, I., and Garcia-Foncillas, J. Vascular endothelial advance agency (VEGF) and melanoma. N-acetylcysteine downregulates VEGF assembly in vitro. Cytokine 2000;12(4):374-378. View abstract.

Reid, D. and Hazell, W. Paracetamol poisoning: which nomogram should we use? Emerg.Med (Fremantle.) 2003;15(5-6):486-496. View abstract.

Reid, M. B. Free radicals and beef fatigue: Of ROS, canaries, and the IOC. Free Radic.Biol Med 1-15-2008;44(2):169-179. View abstract.

Reid, M. B., Stokic, D. S., Koch, S. M., Khawli, F. A., and Leis, A. A. N-acetylcysteine inhibits beef fatigue in humans. J Clin Invest 1994;94(6):2468-2474. View abstract.

Remington, R., Chan, A., Paskavitz, J., and Shea, T. B. Ability of a vitamin/nutriceutical conception for moderate-stage to later-stage Alzheimer's disease: a placebo-controlled pilot study. Am.J Alzheimers.Dis Added Demen. 2009;24(1):27-33. View abstract.

Renke, M., Tylicki, L., Rutkowski, P., Larczynski, W., Aleksandrowicz, E., Lysiak-Szydlowska, W., and Rutkowski, B. The aftereffect of N-acetylcysteine on proteinuria and markers of tubular abrasion in non-diabetic patients with abiding branch disease. A placebo-controlled, randomized, open, cross-over study. Branch Claret Press Res 2008;31(6):404-410. View abstract.

Reynard, K., Riley, A., and Walker, B. E. Respiratory arrest afterwards N-acetylcysteine for paracetamol overdose. Lancet 9-12-1992;340(8820):675. View abstract.

Riise, G. C., Larsson, S., Larsson, P., Jeansson, S., and Andersson, B. A. The intrabronchial microbial flora in abiding bronchitis patients: a ambition for N-acetylcysteine therapy? Eur.Respir.J 1994;7(1):94-101. View abstract.

Ristikankare, A., Kuitunen, T., Kuitunen, A., Uotila, L., Vento, A., Suojaranta-Ylinen, R., Salmenpera, M., and Poyhia, R. Abridgement of renoprotective aftereffect of i.v. N-acetylcysteine in patients with abiding renal abortion ability cardiac surgery. Br J Anaesth. 2006;97(5):611-616. View abstract.

Rivabene, R., Viora, M., Matarrese, P., Rainaldi, G., D'Ambrosio, A., and Malorni, W. N-acetyl-cysteine enhances corpuscle adherence backdrop of epithelial and lymphoid cells. Corpuscle Biol.Int. 1995;19(8):681-686. View abstract.

Rizk, A. Y., Bedaiwy, M. A., and Al Inany, H. G. N-acetyl-cysteine is a atypical accessory to clomiphene citrate in clomiphene citrate-resistant patients with polycystic ovary syndrome. Fertil.Steril. 2005;83(2):367-370. View abstract.

Roberts, R. L., Aroda, V. R., and Ank, B. J. N-acetylcysteine enhances antibody-dependent cellular cytotoxicity in neutrophils and mononuclear beef from advantageous adults and animal immunodeficiency virus-infected patients. J Infect.Dis. 1995;172(6):1492-1502. View abstract.

Robinson, N., Brattsand, R., and Dahlback, M. Aftereffect of articulate N-acetylcysteine (NAC) on aggregate and albumin agreeable of respiratory amplitude aqueous but not on epithelial secretory corpuscle cardinal in "smoking" rats. Eur.Respir.J 1990;3(3):304-310. View abstract.

Rodenstein, D., DeCoster, A., and Gazzaniga, A. Pharmacokinetics of articulate acetylcysteine: absorption, bounden and metabolism in patients with respiratory disorders. Clin Pharmacokinet. 1978;3(3):247-254. View abstract.

Rodrigues, A. J., Evora, P. R., Bassetto, S., Alves, L., Jr., Scorzoni, Filho A., Origuela, E. A., and Vicente, W. V. Claret cardioplegia with N-acetylcysteine may abate coronary endothelial activation and myocardial oxidative stress. Affection Surg Forum 2009;12(1):E44-E48. View abstract.

Roederer, M., Staal, F. J., Raju, P. A., Ela, S. W., Herzenberg, L. A., and Herzenberg, L. A. Cytokine-stimulated animal immunodeficiency virus archetype is inhibited by N-acetyl-L-cysteine. Proc Natl.Acad.Sci U.S.A 1990;87(12):4884-4888. View abstract.

Roes, E. M., Raijmakers, M. T., Boo, T. M., Zusterzeel, P. L., Merkus, H. M., Peters, W. H., and Steegers, E. A. Articulate N-acetylcysteine administering does not stabilise the action of accustomed astringent preeclampsia. Eur.J Obstet.Gynecol.Reprod.Biol 2006;127(1):61-67. View abstract.

Rogers, D. F. and Jeffery, P. K. Inhibition by articulate N-acetylcysteine of cigarette smoke-induced "bronchitis" in the rat. Exp.Lung Res 1986;10(3):267-283. View abstract.

Rogers, D. F. Mucoactive agents for airway fungus hypersecretory diseases. Respir.Care 2007;52(9):1176-1193. View abstract.

Rogers, D. F., Godfrey, R. W., Majumdar, S., and Jeffery, P. K. Articulate N-acetylcysteine speeds changeabout of cigarette smoke-induced close corpuscle hyperplasia in the rat. Exp.Lung Res 1988;14(1):19-35. View abstract.

Romano, C., Gargani, G. F., Minicucci, L., and Nantron, M. [Controlled analytic abstraction on the action of a new mucoregulating biologic in adverse bronchial anatomy with a apparent hypersecretory feature. The pediatric experience]. Minerva Pediatr 2-15-1984;36(3):127-138. View abstract.

Rosner, M. H. and Okusa, M. D. Astute branch abrasion associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1(1):19-32. View abstract.

Rumack, B. H. Acetaminophen hepatotoxicity: the aboriginal 35 years. J Toxicol.Clin Toxicol. 2002;40(1):3-20. View abstract.

Rumack, B. H. and Matthew, H. Acetaminophen contagion and toxicity. Pediatrics 1975;55(6):871-876. View abstract.

Rumack, B. H., Peterson, R. C., Koch, G. G., and Amara, I. A. Acetaminophen overdose. 662 cases with appraisal of articulate acetylcysteine treatment. Arch Intern Med 2-23-1981;141(3 Spec No):380-385. View abstract.

Rumiris, D., Purwosunu, Y., Wibowo, N., Farina, A., and Sekizawa, A. Lower amount of preeclampsia afterwards antioxidant supplementation in abundant women with low antioxidant status. Hypertens.Pregnancy. 2006;25(3):241-253. View abstract.

Sadowska, A. M., Keenoy, B., Vertongen, T., Schippers, G., Radomska-Lesniewska, D., Heytens, E., and De Backer, W. A. Aftereffect of N-acetylcysteine on neutrophil activation markers in advantageous volunteers: in vivo and in vitro study. Pharmacol Res 2006;53(3):216-225. View abstract.

Sadowska, A. M., Manuel, Y. Keenoy, and De Backer, W. A. Antioxidant and anti-inflammatory ability of NAC in the assay of COPD: antagonistic in vitro and in vivo dose-effects: a review. Pulm.Pharmacol Ther 2007;20(1):9-22. View abstract.

Sadowska, A. M., Verbraecken, J., Darquennes, K., and De Backer, W. A. Role of N-acetylcysteine in the administering of COPD. Int J Chron.Obstruct.Pulmon.Dis. 2006;1(4):425-434. View abstract.

Safarinejad, M. R. and Safarinejad, S. Ability of selenium and/or N-acetyl-cysteine for convalescent berry ambit in barren men: a double-blind, placebo controlled, randomized study. J Urol. 2009;181(2):741-751. View abstract.

Sahin, G., Yalcin, A. U., and Akcar, N. Aftereffect of N-acetylcysteine on endothelial dysfunction in dialysis patients. Claret Purif. 2007;25(4):309-315. View abstract.

Salahudeen, A., Poovala, V., Parry, W., Pande, R., Kanji, V., Ansari, N., Morrow, J., and Roberts, J. Cisplatin induces N-acetyl cysteine suppressible F2-isoprostane assembly and abrasion in renal tubular epithelial cells. J.Am.Soc.Nephrol. 1998;9(8):1448-1455. View abstract.

Salom, M. G., Ramirez, P., Carbonell, L. F., Lopez, Conesa E., Cartagena, J., Quesada, T., Parrilla, P., and Fenoy, F. J. Careful aftereffect of N-acetyl-L-cysteine on the renal abortion induced by inferior vena cava occlusion. Transplantation 5-27-1998;65(10):1315-1321. View abstract.

Sanders, K. M., Kotowicz, M. A., and Nicholson, G. C. Abeyant role of the antioxidant N-acetylcysteine in slowing cartilage assimilation in aboriginal post-menopausal women: a pilot study. Transl.Res 2007;150(4):215. View abstract.

Sandhu, C., Belli, A. M., and Oliveira, D. B. The role of N-acetylcysteine in the blockage of contrast-induced nephrotoxicity. Cardiovasc.Intervent.Radiol. 2006;29(3):344-347. View abstract.

Sandhu, C., Belli, A. M., and Oliveira, D. B. The role of N-acetylcysteine in the blockage of contrast-induced nephrotoxicity. Cardiovasc.Intervent.Radiol. 2006;29(3):344-347. View abstract.

Sandilands, E. A. and Bateman, D. N. Adverse reactions associated with acetylcysteine. Clin Toxicol.(Phila) 2009;47(2):81-88. View abstract.

Santiago, F. M., Bueno, P., Olmedo, C., Muffak-Granero, K., Comino, A., Serradilla, M., Mansilla, A., Villar, J. M., Garrote, D., and Ferron, J. A. Aftereffect of N-acetylcysteine administering on intraoperative claret levels of interleukin-4 and interleukin-10 in alarmist displace recipients. Transplant.Proc 2008;40(9):2978-2980. View abstract.

Saricaoglu, F., Dal, D., Salman, A. E., Atay, O. A., Doral, M. N., Salman, M. A., Kilinc, K., and Aypar, U. Aftereffect of low-dose N-acetyl-cysteine beverage on tourniquet-induced ischaemia-reperfusion abrasion in arthroscopic knee surgery. Acta Anaesthesiol.Scand 2005;49(6):847-851. View abstract.

Schultz, M. J., Baas, M. C., van der Sluijs, H. P., Stamkot, G. A., and Smit, W. N-acetylcysteine and added antitoxin measures for contrast-induced nephropathy in the accelerated affliction unit. Curr Med Chem. 2006;13(21):2565-2570. View abstract.

Semerdjian, R. and et al. Astute changes in airway attrition as an basis of biologic effects. Clin Res 1967;15:434.

Shahin, A. Y., Hassanin, I. M., Ismail, A. M., Kruessel, J. S., and Hirchenhain, J. Aftereffect of articulate N-acetyl cysteine on alternate preterm action afterward assay for bacterial vaginosis. Int J Gynaecol.Obstet. 2009;104(1):44-48. View abstract.

Shaikh, Z. A., Vu, T. T., and Zaman, K. Oxidative accent as a apparatus of abiding cadmium-induced hepatotoxicity and renal toxicity and aegis by antioxidants. Toxicol.Appl Pharmacol 2-1-1999;154(3):256-263. View abstract.

Shaw, A. Assurance of N-acetylcysteine in assay of meconium obstruction of the newborn. J Pediatr Surg 1969;4(1):119-125. View abstract.

Sheffner, A. L., Medler, E. M., JACOBS, L. W., and Sarett, H. P. THE IN VITRO REDUCTION IN VISCOSITY OF HUMAN TRACHEOBRONCHIAL SECRETIONS BY ACETYLCYSTEINE. Am Rev.Respir.Dis. 1964;90:721-729. View abstract.

Sheikh-Hamad, D., Timmins, K., and Jalali, Z. Cisplatin-induced renal toxicity: accessible changeabout by N-acetylcysteine treatment. J Am Soc Nephrol. 1997;8(10):1640-1644. View abstract.

Shohrati, M., Aslani, J., Eshraghi, M., Alaedini, F., and Ghanei, M. Analysis aftereffect of N-acetyl cysteine on alacrity gas apparent patients: evaluating analytic aspect in patients with broken pulmonary action test. Respir.Med 2008;102(3):443-448. View abstract.

Siriwardena, A. K., Mason, J. M., Balachandra, S., Bagul, A., Galloway, S., Formela, L., Hardman, J. G., and Jamdar, S. Randomised, bifold blind, placebo controlled balloon of intravenous antioxidant (n-acetylcysteine, selenium, vitamin C) assay in astringent astute pancreatitis. Gut 2007;56(10):1439-1444. View abstract.

Sisillo, E., Ceriani, R., Bortone, F., Juliano, G., Salvi, L., Veglia, F., Fiorentini, C., and Marenzi, G. N-acetylcysteine for blockage of astute renal abortion in patients with abiding renal dearth ability cardiac surgery: a prospective, randomized, analytic trial. Crit Affliction Med 2008;36(1):81-86. View abstract.

Sivilotti, M. L., Good, A. M., Yarema, M. C., Juurlink, D. N., and Johnson, D. W. A new augur of toxicity afterward acetaminophen balance based on pretreatment exposure. Clin Toxicol.(Phila) 2005;43(4):229-234. View abstract.

Sjodin, K., Nilsson, E., Hallberg, A., and Tunek, A. Metabolism of N-acetyl-L-cysteine. Some structural requirements for the deacetylation and after-effects for the articulate bioavailability. Biochem.Pharmacol 11-15-1989;38(22):3981-3985. View abstract.

Slavik, M. and Saiers, J. H. Appearance I analytic abstraction of acetylcysteine's preventing ifosfamide-induced hematuria. Semin.Oncol 1983;10(1 Suppl 1):62-65. View abstract.

Smilkstein, M. J., Bronstein, A. C., Linden, C., Augenstein, W. L., Kulig, K. W., and Rumack, B. H. Acetaminophen overdose: a 48-hour intravenous N-acetylcysteine assay protocol. Ann Emerg.Med 1991;20(10):1058-1063. View abstract.

Smilkstein, M. J., Knapp, G. L., Kulig, K. W., and Rumack, B. H. Ability of articulate N-acetylcysteine in the assay of acetaminophen overdose. Assay of the civic multicenter abstraction (1976 to 1985). N.Engl.J Med 12-15-1988;319(24):1557-1562. View abstract.

Sochman, J., Vrbska, J., Musilova, B., and Rocek, M. Barricade Admeasurement Limitation: astute N-acetylcysteine aegis (ISLAND trial): basic assay and address afterwards the aboriginal 30 patients. Clin Cardiol. 1996;19(2):94-100. View abstract.

Soghier, L. M. and Brion, L. P. Cysteine, cystine or N-acetylcysteine supplementation in parenterally fed neonates. Cochrane.Database.Syst.Rev. 2006;(4):CD004869. View abstract.

Soltan-Sharifi, M. S., Mojtahedzadeh, M., Najafi, A., Reza, Khajavi M., Reza, Rouini M., Moradi, M., Mohammadirad, A., and Abdollahi, M. Advance by N-acetylcysteine of astute respiratory ache affection through accretion intracellular glutathione, and extracellular thiol molecules and anti-oxidant power: affirmation for basal toxicological mechanisms. Hum Exp.Toxicol. 2007;26(9):697-703. View abstract.

Spapen, H., Zhang, H., Demanet, C., Vleminckx, W., Vincent, J. L., and Huyghens, L. Does N-acetyl-L-cysteine access cytokine acknowledgment during aboriginal animal catchbasin shock? Chest 1998;113(6):1616-1624. View abstract.

Spies, C. D., Reinhart, K., Witt, I., Meier-Hellmann, A., Hannemann, L., Bredle, D. L., and Schaffartzik, W. Access of N-acetylcysteine on aberrant indicators of tissue oxygenation in catchbasin shock patients: after-effects from a prospective, randomized, double-blind study. Crit Affliction Med 1994;22(11):1738-1746. View abstract.

Spies, C., Giese, C., Meier-Hellmann, A., Specht, M., Hannemann, L., Schaffartzik, W., and Reinhart, K. [The aftereffect of prophylactically administered n-acetylcysteine on analytic indicators for tissue oxygenation during hyperoxic blast in cardiac accident patients]. Anaesthesist 1996;45(4):343-350. View abstract.

Spiller, H. A., Winter, M. L., Klein-Schwartz, W., and Bangh, S. A. Ability of activated charcoal administered added than four hours afterwards acetaminophen overdose. J Emerg.Med 2006;30(1):1-5. View abstract.

Sridharan S, Ramamurthy N, and Shyamala CS. In vitro appraisal of the anticancer aftereffect of N-acetylcysteine on articulate blight corpuscle line. Indian Journal of Pharmacology 2001;33:343-349.

Stacul, F., Adam, A., Becker, C. R., Davidson, C., Lameire, N., McCullough, P. A., and Tumlin, J. Strategies to abate the accident of contrast-induced nephropathy. Am J Cardiol. 9-18-2006;98(6A):59K-77K. View abstract.

Stafanger, G. and Koch, C. N-acetylcysteine in cystic fibrosis and Pseudomonas aeruginosa infection: analytic score, spirometry and ciliary motility. Eur.Respir.J 1989;2(3):234-237. View abstract.

Stafanger, G., Garne, S., Howitz, P., Morkassel, E., and Koch, C. The analytic aftereffect and the aftereffect on the ciliary action of articulate N-acetylcysteine in patients with cystic fibrosis and primary ciliary dyskinesia. Eur.Respir.J 1988;1(2):161-167. View abstract.

STAMM, S. J. and DOCTER, J. CLINICAL EVALUATION OF ACETYLCYSTEINE AS A MUCOLYTIC AGENT IN CYSTIC FIBROSIS. Dis.Chest 1965;47:414-420. View abstract.

Stanislawski, L., Soheili-Majd, E., Perianin, A., and Goldberg, M. Dental alleviation biomaterials abet glutathione burning in able animal gingival fibroblast: careful aftereffect of N-acetyl cysteine. J.Biomed.Mater.Res. 9-5-2000;51(3):469-474. View abstract.

Stavem, K. [Anaphylactic acknowledgment to N-acetylcysteine afterwards contagion with paracetamol]. Tidsskr.Nor Laegeforen. 5-30-1997;117(14):2038-2039. View abstract.

Steil, E. and Niessen, K. H. Expiratory ventilatory accommodation abstracts in accouchement with cystic fibrosis advised by articulate acetylcysteine. Eur.J Respir.Dis.Suppl 1980;111:132-133. View abstract.

Stenstrom, D. A., Muldoon, L. L., Armijo-Medina, H., Watnick, S., Doolittle, N. D., Kaufman, J. A., Peterson, D. R., Bubalo, J., and Neuwelt, E. A. N-acetylcysteine use to anticipate adverse medium-induced nephropathy: abortive appearance III trials. J Vasc.Interv.Radiol. 2008;19(3):309-318. View abstract.

Stephan, U. and Sitzmann, F. C. [On a new achievability of alleviative pulmonary complications of mucoviscidosis]. Dtsch.Med Wochenschr. 12-3-1965;90(49):2192-2197. View abstract.

Stephan, U., Bowing, B., Goering, U., Wiesemann, H. G., Reinhardt, M., Hirche, H., and Brandt, H. Acetylcysteine in the articulate mucolytic assay of cystic fibrosis. Eur.J Respir.Dis.Suppl 1980;111:127-131. View abstract.

Stewart, S., Prince, M., Bassendine, M., Hudson, M., James, O., Jones, D., Record, C., and Day, C. P. A randomized balloon of antioxidant assay abandoned or with corticosteroids in astute alcoholic hepatitis. J Hepatol. 2007;47(2):277-283. View abstract.

Stey, C., Steurer, J., Bachmann, S., Medici, T. C., and Tramer, M. R. The aftereffect of articulate N-acetylcysteine in abiding bronchitis: a quantitative analytical review. Eur.Respir.J 2000;16(2):253-262. View abstract.

Sucu, N., Cinel, I., Unlu, A., Aytacoglu, B., Tamer, L., Kocak, Z., Karaca, K., Gul, A., Dikmengil, M., Atik, U., and Oral, U. N-acetylcysteine for preventing pump-induced oxidoinflammatory acknowledgment during cardiopulmonary bypass. Surg Today 2004;34(3):237-242. View abstract.

Sunman, W., Hughes, A. D., and Sever, P. S. Anaphylactoid acknowledgment to intravenous acetylcysteine. Lancet 5-16-1992;339(8803):1231-1232. View abstract.

Suter, P. M., Domenighetti, G., Schaller, M. D., Laverriere, M. C., Ritz, R., and Perret, C. N-acetylcysteine enhances accretion from astute lung abrasion in man. A randomized, double-blind, placebo-controlled analytic study. Chest 1994;105(1):190-194. View abstract.

Sutherland, E. R., Crapo, J. D., and Bowler, R. P. N-acetylcysteine and exacerbations of abiding adverse pulmonary disease. COPD. 2006;3(4):195-202. View abstract.

Tandon, S. K., Prasad, S., and Singh, S. Chelation in metal intoxication: access of cysteine or N-acetyl cysteine on the ability of 2,3-dimercaptopropane-1-sulphonate in the assay of cadmium toxicity. J Appl Toxicol 2002;22(1):67-71. View abstract.

Tariq, M., Morais, C., Sobki, S., Al, Sulaiman M., and Al, Khader A. N-acetylcysteine attenuates cyclosporin-induced nephrotoxicity in rats. Nephrol.Dial.Transplant. 1999;14(4):923-929. View abstract.

Tattersall, A. B., Bridgman, K. M., and Huitson, A. Acetylcysteine (Fabrol) in abiding bronchitis--a abstraction in accepted practice. J Int Med Res 1983;11(5):279-284. View abstract.

Tattersall, A. B., Bridgman, K. M., and Huitson, A. Irish accepted convenance abstraction of acetylcysteine (Fabrol) in abiding bronchitis. J Int Med Res 1984;12(2):96-101. View abstract.

Tecklin, J. S. and Holsclaw, D. S., Jr. Bronchial arising with aerosol medications in cystic fibrosis. Phys.Ther 1976;56(9):999-1003. View abstract.

ten Dam, M. A. and Wetzels, J. F. Toxicity of adverse media: an update. Neth.J Med 2008;66(10):416-422. View abstract.

Thaha, M., Yogiantoro, M., and Tomino, Y. Intravenous N-acetylcysteine during haemodialysis reduces the claret assimilation of homocysteine in patients with end-stage renal disease. Clin Biologic Investig. 2006;26(4):195-202. View abstract.

Thanopoulou, E., Baltayiannis, N., and Lykogianni, V. Nutritional aspects apropos lung blight chemoprevention. J BUON. 2006;11(1):7-20. View abstract.

Tirouvanziam, R., Conrad, C. K., Bottiglieri, T., Herzenberg, L. A., Moss, R. B., and Herzenberg, L. A. High-dose articulate N-acetylcysteine, a glutathione prodrug, modulates deepening in cystic fibrosis. Proc Natl.Acad.Sci U.S.A 3-21-2006;103(12):4628-4633. View abstract.

Tolar, J., Orchard, P. J., Bjoraker, K. J., Ziegler, R. S., Shapiro, E. G., and Charnas, L. N-acetyl-L-cysteine improves aftereffect of avant-garde bookish adrenoleukodystrophy. Cartilage Marrow Transplant. 2007;39(4):211-215. View abstract.

Tolley, D. A. and Castro, J. E. Cyclophosphamide-induced cystitis of the urinary float of rats and its treatment. Proc R.Soc Med 1975;68(3):169-170. View abstract.

Tossios, P., Bloch, W., Huebner, A., Raji, M. R., Dodos, F., Klass, O., Suedkamp, M., Kasper, S. M., Hellmich, M., and Mehlhorn, U. N-acetylcysteine prevents acknowledging oxygen species-mediated myocardial accent in patients ability cardiac surgery: after-effects of a randomized, double-blind, placebo-controlled analytic trial. J Thorac.Cardiovasc.Surg 2003;126(5):1513-1520. View abstract.

Tozawa, K., Okamoto, T., Hayashi, Y., Sasaki, S., Kawai, N., and Kohri, K. N-acetyl-L-cysteine enhances chemotherapeutic aftereffect on prostate blight cells. Urol.Res 2002;30(1):53-58. View abstract.

Travaline, J. M., Sudarshan, S., Roy, B. G., Cordova, F., Leyenson, V., and Criner, G. J. Aftereffect of N-acetylcysteine on animal diaphragm backbone and fatigability. Am J Respir.Crit Affliction Med 1997;156(5):1567-1571. View abstract.

Treitinger, A., Spada, C., Masokawa, I. Y., Verdi, J. C., Van Der Sander, Silveira M., Luis, M. C., Reis, M., Ferreira, S. I., and Abdalla, D. S. Aftereffect of N-acetyl-L-cysteine on lymphocyte apoptosis, lymphocyte viability, TNF-alpha and IL-8 in HIV-infected patients ability anti-retroviral treatment. Braz.J Infect.Dis 2004;8(5):363-371. View abstract.

Tsai, C. L., Chang, W. T., Weng, T. I., Fang, C. C., and Chen, W. J. Astute acetaminophen beatitude in Taiwan: outcomes and accident factors. J Formos.Med Assoc. 2004;103(11):830-835. View abstract.

Tsai, C. L., Chang, W. T., Weng, T. I., Fang, C. C., and Walson, P. D. A patient-tailored N-acetylcysteine agreement for astute acetaminophen intoxication. Clin Ther 2005;27(3):336-341. View abstract.

Unverferth, B. J., Magorien, R. D., Balcerzak, S. P., Leier, C. V., and Unverferth, D. V. Aboriginal changes in animal myocardial nuclei afterwards doxorubicin. Blight 7-15-1983;52(2):215-221. View abstract.

Urban, T., Akerlund, B., Jarstrand, C., and Lindeke, B. Neutrophil action and glutathione-peroxidase (GSH-px) action in advantageous individuals afterwards assay with N-acetyl-L-cysteine. Biomed.Pharmacother. 1997;51(9):388-390. View abstract.

Uys, J. D. and LaLumiere, R. T. Glutamate: the new borderland in pharmacotherapy for cocaine addiction. CNS.Neurol.Disord.Drug Targets. 2008;7(5):482-491. View abstract.

Vale, J. A. and Buckley, B. M. Asthma associated with N-acetylcysteine beverage and paracetamol poisoning. Br Med J (Clin Res Ed) 10-22-1983;287(6400):1223. View abstract.

Vale, J. A. and Wheeler, D. C. Anaphylactoid acknowledgment to acetylcysteine. Lancet 10-30-1982;2(8305):988. View abstract.

Vallero, A., Cesano, G., Pozzato, M., Garbo, R., Minelli, M., Quarello, F., and Formica, M. [Contrast nephropathy in cardiac procedures: no advantages with antibacterial use of N-acetylcysteine (NAC)]. G.Ital.Nefrol. 2002;19(5):529-533. View abstract.

van Dalen, E. C., Caron, H. N., Dickinson, H. O., and Kremer, L. C. Cardioprotective interventions for blight patients accepting anthracyclines. Cochrane.Database.Syst.Rev. 2008;(2):CD003917. View abstract.

Van Schooten, F. J., Nia, A. B., De Flora, S., D'Agostini, F., Izzotti, A., Camoirano, A., Balm, A. J., Dallinga, J. W., Bast, A., Haenen, G. R., Van't Veer, L., Baas, P., Sakai, H., and van Zandwijk, N. Furnishings of articulate administering of N-acetyl-L-cysteine: a multi- biomarker abstraction in smokers. Blight Epidemiol.Biomarkers Prev. 2002;11(2):167-175. View abstract.

van Zandwijk, N., Maas, L. M., Breedijk, A., Godschalk, R. W. L., Sakai, H., Wigbout, G., Baas, P., Van't Veer, L., De Flora, S., and Van Schooten, F. J. Aromatic DNA adduct levels in alveolar macrophages and lymphocytes of smoker volunteers; Furnishings of N-acetylcysteine (NAC) supplementation. Lung Blight 1997;18(Suppl 1):187.

Vats, P., Singh, V. K., Singh, S. N., and Singh, S. B. Aerial distance induced anorexia: aftereffect of changes in leptin and oxidative accent levels. Nutr Neurosci. 2007;10(5-6):243-249. View abstract.

Vecchiarelli, A., Dottorini, M., Pietrella, D., Cociani, C., Eslami, A., Todisco, T., and Bistoni, F. Macrophage activation by N-acetyl-cysteine in COPD patients. Chest 1994;105(3):806-811. View abstract.

Venkataraman, R. Can we anticipate astute branch injury? Crit Affliction Med 2008;36(4 Suppl):S166-S171. View abstract.

Ventura, P., Panini, R., Pasini, M. C., Scarpetta, G., and Salvioli, G. N -Acetyl-cysteine reduces homocysteine claret levels afterwards distinct intravenous administering by accretion thiols urinary excretion. Pharmacol.Res. 1999;40(4):345-350. View abstract.

Verstraeten, J. M. Mucolytic assay in abiding adverse pulmonary disease. Double-blind allusive analytic balloon with N-acetylcysteine, bromhexine and placebo. Acta Tuberc.Pneumol.Belg. 1979;70(1):71-80. View abstract.

Walker RE, Lane HC, and Boenning CM. The safety, pharmacokinetics, and antiviral action of N-acetylcysteine in HIV-infected individuals. J Corpuscle Biochem Suppl 1992;16:89.

Walmsley, S. L., Khorasheh, S., Singer, J., and Djurdjev, O. A randomized balloon of N-acetylcysteine for blockage of trimethoprim-sulfamethoxazole hypersensitivity reactions in Pneumocystis carinii pneumonia prophylaxis (CTN 057). Canadian HIV Trials Network 057 Abstraction Group. J Acquir.Immune.Defic.Syndr.Hum Retrovirol. 12-15-1998;19(5):498-505. View abstract.

[caption id="" align="aligncenter" width="638"]Nursing care plan for dengue pt | epistaxis care plan
[/caption]

Walters, M. T., Rubin, C. E., Keightley, S. J., Ward, C. D., and Cawley, M. I. A double-blind, cross-over, abstraction of articulate N-acetylcysteine in Sjogren's syndrome. Scand J Rheumatol.Suppl 1986;61:253-258. View abstract.

Walton, N. G., Mann, T. A., and Shaw, K. M. Anaphylactoid acknowledgment to N-acetylcysteine. Lancet 12-15-1979;2(8155):1298. View abstract.

Webb, J. G., Pate, G. E., Humphries, K. H., Buller, C. E., Shalansky, S., Al, Shamari A., Sutander, A., Williams, T., Fox, R. S., and Levin, A. A randomized controlled balloon of intravenous N-acetylcysteine for the blockage of contrast-induced nephropathy afterwards cardiac catheterization: abridgement of effect. Am Affection J 2004;148(3):422-429.

Webb, J. G., Pate, G. E., Humphries, K. H., Buller, C. E., Shalansky, S., Al, Shamari A., Sutander, A., Williams, T., Fox, R. S., and Levin, A. A randomized controlled balloon of intravenous N-acetylcysteine for the blockage of contrast-induced nephropathy afterwards cardiac catheterization: abridgement of effect. Am.Heart J 2004;148(3):422-429. View abstract.

WEBB, W. R. Analytic evaluaton of a new mucolytic agent, acetyl-cysteine. J Thorac.Cardiovasc.Surg 1962;44:330-343. View abstract.

Weinbroum, A. A., Kluger, Y., Ben, Abraham R., Shapira, I., Karchevski, E., and Rudick, V. Lung preconditioning with N-acetyl-L-cysteine prevents reperfusion abrasion afterwards alarmist no flow-reflow: a dose-response study. Transplantation 1-27-2001;71(2):300-306. View abstract.

Wijeysundera, D. N., Beattie, W. S., Rao, V., Granton, J. T., and Chan, C. T. N-acetylcysteine for preventing astute branch abrasion in cardiac anaplasty patients with above-mentioned abstinent renal insufficiency. Can J Anaesth. 2007;54(11):872-881. View abstract.

Wijeysundera, D. N., Karkouti, K., Rao, V., Granton, J. T., Chan, C. T., Raban, R., Carroll, J., Poonawala, H., and Beattie, W. S. N-acetylcysteine is associated with added claret accident and claret artefact appliance during cardiac surgery. Crit Affliction Med 2009;37(6):1929-1934. View abstract.

Wijnen, M. H., Roumen, R. M., Vader, H. L., and Goris, R. J. A multiantioxidant supplementation reduces accident from ischaemia reperfusion in patients afterwards lower anatomy ischaemia. A randomised trial. Eur.J Vasc.Endovasc.Surg 2002;23(6):486-490. View abstract.

Wilpart, M., Speder, A., and Roberfroid, M. Anti-initiation action of N-acetylcysteine in beginning colonic carcinogenesis. Blight Lett 1986;31(3):319-324. View abstract.

Winniford, M. D., Kennedy, P. L., Wells, P. J., and Hillis, L. D. Potentiation of nitroglycerin-induced coronary addendum by N-acetylcysteine. Apportionment 1986;73(1):138-142. View abstract.

Witschi, A., Junker, E., Schranz, C., Speck, R. F., and Lauterburg, B. H. Supplementation of N-acetylcysteine fails to access glutathione in lymphocytes and claret of patients with AIDS. AIDS Res Hum Retroviruses 1995;11(1):141-143. View abstract.

Woo, O. F., Mueller, P. D., Olson, K. R., Anderson, I. B., and Kim, S. Y. Shorter continuance of articulate N-acetylcysteine assay for astute acetaminophen overdose. Ann Emerg.Med 2000;35(4):363-368. View abstract.

Wu, J., Levy, E. M., and Black, P. H. 2-Mercaptoethanol and n-acetylcysteine enhance T corpuscle antecedents accumulation in AIDS and ARC. Clin Exp.Immunol. 1989;77(1):7-10. View abstract.

Yesilbursa, D., Serdar, A., Senturk, T., Serdar, Z., Sag, S., and Cordan, J. Aftereffect of N-acetylcysteine on oxidative accent and ventricular action in patients with myocardial infarction. Affection Vessels 2006;21(1):33-37. View abstract.

Yilmaz, H., Sahin, S., Sayar, N., Tangurek, B., Yilmaz, M., Nurkalem, Z., Onturk, E., Cakmak, N., and Bolca, O. Furnishings of folic acerbic and N-acetylcysteine on claret homocysteine levels and endothelial action in patients with coronary avenue disease. Acta Cardiol. 2007;62(6):579-585. View abstract.

Yim, C. Y., Hibbs, J. B., Jr., McGregor, J. R., Galinsky, R. E., and Samlowski, W. E. Use of N-acetyl cysteine to access intracellular glutathione during the consecration of antitumor responses by IL-2. J Immunol. 6-15-1994;152(12):5796-5805. View abstract.

Zagler, A., Azadpour, M., Mercado, C., and Hennekens, C. H. N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials. Am Affection J 2006;151(1):140-145. View abstract.

Zhang, H., Spapen, H., Nguyen, D. N., Benlabed, M., Buurman, W. A., and Vincent, J. L. Careful furnishings of N-acetyl-L-cysteine in endotoxemia. Am.J.Physiol 1994;266(5 Pt 2):H1746-H1754. View abstract.

Zhang, H., Spapen, H., Nguyen, D. N., Rogiers, P., Bakker, J., and Vincent, J. L. Furnishings of N-acetyl-L-cysteine on bounded claret breeze during endotoxic shock. Eur.Surg Res 1995;27(5):292-300. View abstract.

Zoccali, C., Mallamaci, F., and Tripepi, G. It is important to lower homocysteine in dialysis patients. Semin.Dial. 2007;20(6):530-533. View abstract.

Adair JC, Knoefel JE, Morgan N. Controlled balloon of N-acetylcysteine for patients with apparent Alzheimer's disease. Neurology 2001;57:1515-7. View abstract.

Anfossi G, Russo I, Massucco P, et al. N-acetyl-L-cysteine exerts absolute anti-aggregating aftereffect on animal platelets. Eur J Clin Invest 2001;31:452-61.. View abstract.

Ardissino D, Merlini PA, Savonitto S, et al. Aftereffect of transdermal nitroglycerin or N-acetylcysteine, or both, in the abiding assay of ambiguous angina pectoris. J Am Coll Cardiol 1997;29:941-7. View abstract.

Arstall MA, Yang J, Stafford I, et al. N-acetylcysteine in aggregate with nitroglycerin and streptokinase for the assay of evolving astute myocardial infarction. Assurance and biochemical effects. Apportionment 1995;92:2855-62. View abstract.

Bailey B, McGuigan MA. Administering of anaphylactoid reactions to intravenous N-acetylcysteine. Ann Emerg Med 1998;31:710-5. View abstract.

Behr J, Maier K, Degenkolb B, et al. Antioxidative and analytic furnishings of high-dose N-acetylcysteine in fibrosing alveolitis. Accessory assay to aliment immunosuppression. Am J Respir Crit Affliction Med 1997;156:1897-901. View abstract.

Bostom AG, Shemin D, Yoburn D, et al. Abridgement of aftereffect of articulate N-acetylcysteine on the astute dialysis-related blurred of absolute claret homocysteine in hemodialysis patients. Atherosclerosis 1996;120:241-4. View abstract.

Chamberlain JM, Gorman RL, Oderda GM, Klein-Schwartz W, Klein BL. Use of activated charcoal in a apish contagion with acetaminophen: a new loading dosage for N-acetylcysteine? Ann Emerg Med. 1993;22(9):1398-402. View abstract.

Chyka PA, Butler AY, Holliman BJ, Herman MI. Utility of acetylcysteine in alleviative poisonings and adverse biologic reactions. Biologic Saf 2000;22:123-48. View abstract.

De Flora S, Grassi C, Carati L. Attenuation of influenza-like symptomatology and advance of cell-mediated amnesty with abiding N-acetylcysteine treatment. Eur Respir J 1997;10:1535-41. View abstract.

De Rosa SC, Zaretsky MD, Dubs JG, et al. N-acetylcysteine replenishes glutathione in HIV infection. Eur J Clin Invest 2000;30:915-29.

Deharo E, Barkan D, Krugliak M, Golenser J, Ginsburg H. Potentiation of the antimalarial action of chloroquine in rodent malaria by drugs accepted to abate cellular glutathione levels. Biochem Pharmacol. 2003;66(5):809-17. View abstract.

Dickey DT, Muldoon LL, Kraemer DF, Neuwelt EA. Aegis adjoin cisplatin-induced ototoxicity by N-acetylcysteine in a rat model. Hear Res 2004;193:25-30. View abstract.

Dresdale AR, Barr LH, Bonow RO, et al. -to-be randomized abstraction of the role of N-acetyl cysteine in abandoning doxorubicin-induced cardiomyopathy. Am J Clin Oncol 1982;5:657-63. View abstract.

Duan M, Qiu J, Laurell G, et al, Dosage and time-dependent aegis of the antioxidant N-L-acetycysteine adjoin actuation babble trauma. Hear Res 2004;192:1-9. View abstract.

Ekins BR, Ford DC, Thompson MI, et al. The aftereffect of activated charcoal on N-acetylcysteine assimilation in accustomed subjects. Am J Emerg Med. 1987;5(6):483-7. View abstract.

Estensen RD, Levy M, Klopp SJ, et al. N-acetylcysteine abolishment of the proliferative basis in the colon of patients with antecedent adenomatous colonic polyps. Blight Lett 1999;147:109-14. View abstract.

Ghio S, de Servi S, Perotti R, et al. Altered susceptibility to the development of nitroglycerin altruism in the arterial and venous apportionment in humans- furnishings of N-acetylcysteine administration. Apportionment 1992;86:798-802. View abstract.

Gillissen A, Nowak D. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy. Respir Med 1998;92:609-23. View abstract.

Grandjean EM, Berthet P, Ruffmann R, Leuenberger P. Ability of articulate abiding N-acetylcysteine in abiding bronchopulmonary disease: a meta-analysis of appear double-blind, placebo-controlled analytic trials. Clin Ther 2000;22:209-21. View abstract.

Grant JE, Odlaug BL, Kim SW. N-acetylcysteine, a glutamate modulator, in the assay of trichotillomania: a double-blind, placebo-controlled study. Arch Gen Psychiatry 2009;66:756-63. View abstract.

Haase M, Haase-Fielitz A, Ratnaike S, et al. N-Acetylcysteine does not artifactually lower claret creatinine concentration. Nephrol Dial Transplant. 2008;23(5):1581-7. View abstract.

Hogan JC, Lewis MJ, Henderson AH. Abiding administering of N-acetylcysteine fails to anticipate nitrate altruism in patients with abiding angina pectoris. Br J Clin Pharmacol 1990;30:573-7. View abstract.

Hogan JC, Lewis MJ, Henderson AH. N-acetylcysteine fails to abate haemodynamic altruism to glyceryl trinitrate in advantageous volunteers. Br J Clin Pharmacol 1989;28:421-6. View abstract.

Holoye PY, Duelge J, Hansen RM, et al. Prophylaxis of Ifosamide toxicity with articulate acetylcysteine. Semin Oncol 1983;10:66-71. View abstract.

Holt S, Goodier D, Marley R, et al. Advance in renal action in hepatorenal affection with N-acetylcysteine. Lancet 1999;353:294-5. View abstract.

Horowitz JD, Henry CA, Syrjanen ML, et al. Nitroglycerine/N-acetylcysteine in the administering of ambiguous angina pectoris. Eur Affection J 1988;9:95-100. View abstract.

Horowitz RS, Dart RC, Jarvie DR, et al. Placental alteration of N-acetylcysteine afterward animal affectionate acetaminophen toxicity. J Toxicol Clin Toxicol 1997;35:447-51. View abstract.

Hurd RW, Wilder BJ, Helveston WR, et al. Assay of four ancestors with accelerating myoclonus attack of the Unverricht-Lundborg blazon with N-acetylcysteine. Neurology 1996;47:1264-8. View abstract.

Iversen HK. N-acetylcysteine enhances nitroglycerin-induced cephalalgia and cranial arterial responses. Clin Pharmacol Ther 1992;52:125-33. View abstract.

Jepsen S, Hansen AB. The access of N-acetylcysteine on the altitude of prothrombin time and activated fractional thromboplastin time in advantageous subjects. Scand J Clin Lab Invest 1994;54:543-7. View abstract.

Kelly GS. Analytic applications of N-acetylcysteine. Altern Med Rev 1998;3:114-27. View abstract.

Kopke RD, Jackson RL, Coleman JKM, et al. NAC for noise: From the bank top to the clinic. Hear Res 2007;226:114-25. View abstract.

Kopke RD, Weisskopf PA, Boone JL, et al. Abridgement of noise-induced audition accident application L-NAC and salicylate in the chinchilla. Hear Res 2000;149:138-146. View abstract.

Kroon AA, Demacker PN, Stalenhoef AF. N-acetylcysteine and serum concentrations of lipoprotein(a). J Intern Med 1991;230:519-26. View abstract.

Loehrer PJ Sr, Birch R, Kramer BS, et al. Ifosfamide additional N-acetylcysteine in the assay of baby corpuscle and non-small corpuscle blight of the lung: a Southeastern Blight Abstraction Group Trial. Blight Amusement Rep 1986;70:919-20.

Loehrer PJ, Williams SD, Einhorn LH. N-acetylcysteine and ifosfamide in the assay of unresectable pancreatic adenocarcinoma and adverse testicular cancer. Semin Oncol 1983;10:72-5.

Lorito G, Giordano P, Prosser S, et al. Noise-induced audition loss: a abstraction on the pharmacological aegis in the Sprague Dawley rat with N-acetyl-cysteine. Acta Otorhinolaryngol Ital 2006;26:133-9. View abstract.

Loscalzo J. N-Acetylcysteine potentiates inhibition of platelet accession by nitroglycerin. J Clin Invest. 1985;76(2):703-8. View abstract.

Louwerse ES, Weverling GJ, Bossuyt PM, et al. Randomized, double-blind, controlled balloon of acetylcysteine in amyotrophic crabbed sclerosis. Arch Neurol 1995;52:559-64. View abstract.

Marchetti G, Lodola E, Licciardello L, Colombo A. Use of N-acetylcysteine in the administering of coronary avenue diseases. Cardiologia 1999;44:633-7. View abstract.

Molnar Z, Shearer E, Lowe D. N-Acetylcysteine assay to anticipate the progression of multisystem agency failure: a prospective, randomized, placebo-controlled study. Crit Affliction Med 1999;27:1100-4. View abstract.

Morgan LR, Donley PJ, Harrison EF, Hunter HL. The ascendancy of ifosfamide-induced hematuria with N-acetylcysteine in patients with avant-garde blight of the lung. Semin Oncol 1982;9:71-4.

Morgan LR, Holdiness MR, Gillen LE. N-acetylcysteine: its bioavailability and alternation with ifosfamide metabolites. Semin Oncol 1983;10:56-61.

Morini M, Cai T, Aluigi MG, et al. The role of the thiol N-acetylcysteine in the blockage of bump aggression and angiogenesis. Int J Biol Markers 1999;14:268-71. View abstract.

Munshi NC, Loehrer PJ Sr, Williams SD, et al. Allegory of N-acetylcysteine and mesna as uroprotectors with ifosfamide aggregate chemotherapy in adverse antibody corpuscle tumors. Invest New Drugs 1992;10:159-163.. View abstract.

Murch SJ, Simmons CB, Saxena PK. Melatonin in feverfew and added alleviative plants. Lancet 1997;350:1598-9. View abstract.

North DS, Peterson RG, Krenzelok EP. Aftereffect of activated charcoal administering on acetylcysteine serum levels in humans. Am J Hosp Pharm. 1981;38(7):1022-4. View abstract.

Norton EW. A randomized balloon of vitamin A and vitamin E supplementation for retinitis pigmentosa. Arch Ophthalmol 1993;111:1460. View abstract.

Oldemeyer JB, Biddle WP, Wurdeman RL, et al. Acetylcysteine in the blockage of contrast-induced nephropathy afterwards coronary angiography. Am Affection J 2003;146:E23. . View abstract.

Pannu, N., Wiebe, N., and Tonelli, M. Prophylaxis strategies for contrast-induced nephropathy. JAMA 2006;295(23):2765-2779. View abstract.

Pela R, Calcagni AM, Subiaco S, et al. N-acetylcysteine reduces the deepening amount in patients with abstinent to astringent COPD. Respiration 1999;66:495-500.. View abstract.

Redondo P, Bauza A. Topical N-acetylcysteine for lamellar ichthyosis. Lancet 1999;354:1880. View abstract.

Renzi FP, Donovan JW, Martin TG, Morgan L, Harrison EF. Concomitant use of activated charcoal and N-acetylcysteine. Ann Emerg Med. 1985;14(6):568-72. View abstract.

Ruiz FJ, Salom MG, Inglés AC, et al. N-acetyl-L-cysteine potentiates depressor acknowledgment to captopril and enalaprilat in SHRs. Am J Physiol. 1994;267(3 Pt 2):R767-72. View abstract.

Sekharam M, Trotti A, Cunnick JM, Wu J. Abolishment of fibroblast corpuscle aeon progression in G1 appearance by N-acetylcysteine. Toxicol Appl Pharmacol 1998;149:210-6. View abstract.

Shyu KG, Cheng JJ, Kuan P. Acetylcysteine protects adjoin astute renal accident in patients with aberrant renal action ability a coronary procedure. J Am Coll Cardiol 2002;40:1383-8.. View abstract.

Spiller HA, Krenzelok EP, Grande GA, et al. A -to-be appraisal of the aftereffect of activated charcoal afore articulate N-acetylcysteine in acetaminophen overdose. Ann Emerg Med 1994;23:519-23. View abstract.

Tam J, Nash EF, Ratjen F, et al. Nebulized and articulate thiol derivatives for pulmonary ache in cystic fibrosis. Cochrane Database Syst Rev. 2013;7:CD007168. View abstract.

Tenenbein PK, Sitar DS, Tenenbein M. Alternation amid N-acetylcysteine and activated charcoal: implications for the assay of acetaminophen poisoning. Pharmacotherapy 2001;21:1331-6. View abstract.

Tepel M, van der Giet M, Schwarzfeld C, et al. Blockage of radiographic-contrast-agent-induced reductions in renal action by acetylcysteine. N Engl J Med 2000;343:180-4. View abstract.

Tepel M, van der Giet M, Statz M, et al. The antioxidant acetylcysteine reduces cardiovascular contest in patients with end-stage renal failure: a randomized, controlled trial. Apportionment 2003;107:992-5.. View abstract.

Unverferth DV, Jagadeesh JM, Unverferth Bj, et al. Attempt to anticipate doxorubicin-induced astute animal myocardial morphologic accident with acetylcysteine. J Natl Blight Inst 1983;71:917-20. View abstract.

Vadoud-Seyedi J, de Dobbeleer G, Simonart T. Assay of haemodialysis-associated pseudoporphyria with N-acetylcysteine: address of two cases. Br J Dermatol 2000;142:580-1. View abstract.

van Zandwijk N, Dalesio O, Pastorino U, et al. EUROSCAN, a randomized balloon of vitamin A and N-acetylcysteine in patients with arch and close blight or lung cancer. For the European Organization for Research and Assay of Blight Arch and Close and Lung Blight Cooperative Groups. J Natl Blight Inst 2000;92:977-86. View abstract.

van Zandwijk N. N-acetylcysteine for lung blight prevention. Chest 1995;107:1437-41. View abstract.

Weinbroum AA, Rudick V, Ben-Abraham R, Karchevski E. N-acetyl-L-cysteine for preventing lung reperfusion abrasion afterwards alarmist ischemia-reperfusion: a accessible bifold careful apparatus in a dose-response study. Transplantation 2000;69:853-9. View abstract.

Wiklund O, Fager G, Andersson A, et al. N-acetylcysteine assay lowers claret homocysteine but not serum lipoprotein(a) levels. Atherosclerosis 1996;119:99-106. View abstract.

Williamson J, Davidson DF, Boag DE. Contamination of a case with N-acetyl cysteine infusion: a account of affected ketonaemia and hyperglycaemia. Ann Clin Biochem. 1989;26 ( Pt 2):207. View abstract.

Young DS. Furnishings of Drugs on Analytic Class Tests 4th ed. Washington: AACC Press, 1995.

Absolon, M. J. and Brown, C. A. Acetylcysteine in kerato-conjunctivitis sicca. Br J Ophthalmol. 1968;52(4):310-316. View abstract.

Adabag, A. S., Ishani, A., Koneswaran, S., Johnson, D. J., Kelly, R. F., Ward, H. B., McFalls, E. O., Bloomfield, H. E., and Chandrashekhar, Y. Utility of N-acetylcysteine to anticipate astute branch abrasion afterwards cardiac surgery: a randomized controlled trial. Am Affection J 2008;155(6):1143-1149. View abstract.

Agarwal, A., Munoz-Najar, U., Klueh, U., Shih, S. C., and Claffey, K. P. N-acetyl-cysteine promotes angiostatin assembly and vascular collapse in an orthotopic archetypal of breast cancer. Am.J.Pathol. 2004;164(5):1683-1696. View abstract.

Agrawal, M., Wodlinger, A. M., Huggins, C. E., Tudor, G. E., Pieper, J. A., O'Reilly, K. P., Denu-Ciocca, C. J., Stouffer, G. A., and Ohman, E. M. Aftereffect of Nacetylcysteine on serum creatinine assimilation in patients with abiding renal dearth who are ability coronary

Ahola, T., Lapatto, R., Raivio, K. O., Selander, B., Stigson, L., Jonsson, B., Jonsbo, F., Esberg, G., Stovring, S., Kjartansson, S., Stiris, T., Lossius, K., Virkola, K., and Fellman, V. N-acetylcysteine does not anticipate bronchopulmonary dysplasia in adolescent infants: a randomized controlled trial. J Pediatr 2003;143(6):713-719. View abstract.

Akerlund, B., Jarstrand, C., Lindeke, B., Sonnerborg, A., Akerblad, A. C., and Rasool, O. Aftereffect of N-acetylcysteine(NAC) assay on HIV-1 infection: a double-blind placebo-controlled trial. Eur.J Clin Pharmacol 1996;50(6):457-461. View abstract.

Akerlund, B., Tynell, E., Bratt, G., Bielenstein, M., and Lidman, C. N-acetylcysteine assay and the accident of baneful reactions to trimethoprim-sulphamethoxazole in primary Pneumocystis carinii prophylaxis in HIV-infected patients. J Infect. 1997;35(2):143-147. View abstract.

Al-Ghonaim, M. and Pannu, N. Blockage and assay of contrast-induced nephropathy. Tech.Vasc.Interv.Radiol. 2006;9(2):42-49. View abstract.

Aliavi, A. L. and Kurbanova, G. A. [Nitric oxide metabolism in the admittance of N-acetylcysteine into the circuitous assay of patients with community-acquired pneumonia]. Probl.Tuberk.Bolezn.Legk. 2007;(9):20-24. View abstract.

Allaqaband, S., Tumuluri, R., Malik, A. M., Gupta, A., Volkert, P., Shalev, Y., and Bajwa, T. K. -to-be randomized abstraction of N-acetylcysteine, fenoldopam, and acrid for blockage of radiocontrast-induced nephropathy. Catheter.Cardiovasc.Interv. 2002;57(3):279-283. View abstract.

Alsalim, W. and Fadel, M. Towards affirmation based emergency medicine: best BETs from the Manchester Royal Infirmary. Articulate methionine compared with intravenous n-acetyl cysteine for paracetamol overdose. Emerg.Med.J. 2003;20(4):366-367. View abstract.

Amin, A. F., Shaaban, O. M., and Bediawy, M. A. N-acetyl cysteine for assay of alternate alien abundance loss. Reprod.Biomed.Online. 2008;17(5):722-726. View abstract.

Andreana, A., Zampino, R., Tonziello, A., Adinolfi, L. E., Utili, R., and Ruggiero, G. Assay with N-acetylcysteine (NAC) or ofloxacin (OFLO) as accessory to INFN bootless to accomplish acknowledgment in abiding hepatitis C patients non responding to IFN alone: a appearance II study. Hepatology 1997;26:218.

Aslam, S. Cardiovascular ache in dialysis patients: do some antihypertensive drugs accept specific antioxidant furnishings or is it aloof claret burden reduction? Does antioxidant assay abate the accident for cardiovascular disease? Curr Opin.Nephrol.Hypertens. 2008;17(1):99-105. View abstract.

Aylward, M., Maddock, J., and Dewland, P. Analytic appraisal of acetylcysteine in the assay of patients with abiding adverse bronchitis: a counterbalanced double-blind balloon with placebo control. Eur.J Respir.Dis.Suppl 1980;111:81-89. View abstract.

Ayonrinde, O. T., Phelps, G. J., Hurley, J. C., and Ayonrinde, O. A. Paracetamol balance and hepatotoxicity at a bounded Australian hospital: a 4-year experience. Intern Med J 2005;35(11):655-660. View abstract.

Azmus, A. D., Gottschall, C., Manica, A., Manica, J., Duro, K., Frey, M., Bulcao, L., and Lima, C. Effectiveness of acetylcysteine in blockage of adverse nephropathy. J Invasive.Cardiol. 2005;17(2):80-84. View abstract.

Badawy, A. H., Abdel Aal, S. F., and Samour, S. A. Alarmist abrasion associated with N-acetylcysteine administration. J Egypt.Soc Parasitol. 1989;19(2):563-571. View abstract.

Badawy, A., Baker El, Nashar A., and El, Totongy M. Clomiphene citrate additional N-acetyl cysteine adjoin clomiphene citrate for assiduity ovulation in the administering of alien infertility: a randomized double-blind controlled trial. Fertil.Steril. 2006;86(3):647-650. View abstract.

Badawy, A., State, O., and Abdelgawad, S. N-Acetyl cysteine and clomiphene citrate for consecration of ovulation in polycystic ovary syndrome: a cross-over trial. Acta Obstet.Gynecol.Scand 2007;86(2):218-222. View abstract.

Baker, C. S., Wragg, A., Kumar, S., De, Palma R., Baker, L. R., and Knight, C. J. A accelerated agreement for the blockage of contrast-induced renal dysfunction: the RAPPID study. J Am Coll.Cardiol. 6-18-2003;41(12):2114-2118. View abstract.

Baker, C. S., Wragg, A., Kumar, S., De, Palma R., Baker, L. R., and Knight, C. J. A accelerated agreement for the blockage of contrast-induced renal dysfunction: the RAPPID study. J Am.Coll.Cardiol. 6-18-2003;41(12):2114-2118. View abstract.

Baker, W. L., Anglade, M. W., Baker, E. L., White, C. M., Kluger, J., and Coleman, C. I. Use of N-acetylcysteine to abate post-cardiothoracic anaplasty complications: a meta-analysis. Eur.J Cardiothorac.Surg 2009;35(3):521-527. View abstract.

Bakker, J., Zhang, H., Depierreux, M., van, Asbeck S., and Vincent, J. L. Furnishings of N-acetylcysteine in endotoxic shock. J Crit Affliction 1994;9(4):236-243. View abstract.

Ballke, E. H., Wiersbitzky, S., Mahner, B., and Konig, A. The aftereffect of N-acetyl-cysteine (Mucosolvin) on the transmural abeyant aberration of the film in children. Padiatr.Grenzgeb. 1992;31(2):97-101. View abstract.

Banner, W., Jr., Koch, M., Capin, D. M., Hopf, S. B., Chang, S., and Tong, T. G. Beginning chelation assay in chromium, lead, and boron beatitude with N-acetylcysteine and added compounds. Toxicol.Appl.Pharmacol 3-30-1986;83(1):142-147. View abstract.

Baran, D. Klinischer Doppelblindversuch mit oralem Acetylcystein und Placebo bei zystischer Fibrose. Therapiewoche 1980;30:2034-2039.

Baranska-Kosakowska, A., Zakliczynski, M., Przybylski, R., and Zembala, M. Role of N-acetylcysteine on renal action in patients afterwards orthotopic affection transplantation ability coronary angiography. Transplant.Proc 2007;39(9):2853-2855. View abstract.

Bariffi, F. and Seccia, A. Ricerca controllata doppio-cieca sull' attivita dell' acetilcisteina per via orale in campo bronco-pneumologico. Clin.Ter. 1973;66:311-320.

Barr, L. F. and Kolodner, K. N-acetylcysteine and fenoldopam assure the renal action of patients with abiding renal dearth ability cardiac surgery. Crit Affliction Med 2008;36(5):1427-1435. View abstract.

Barreto, R. Blockage of contrast-induced nephropathy: the rational use of sodium bicarbonate. Nephrol.Nurs.J 2007;34(4):417-421. View abstract.

Bateman, D. N., Woodhouse, K. W., and Rawlins, M. D. Adverse reactions to N-acetylcysteine. Hum Toxicol. 1984;3(5):393-398. View abstract.

Beckett, G. J., Donovan, J. W., Hussey, A. J., Proudfoot, A. T., and Prescott, L. F. Intravenous N-acetylcysteine, hepatotoxicity and claret glutathione S-transferase in patients with paracetamol overdosage. Hum Exp.Toxicol. 1990;9(3):183-186. View abstract.

Bellomo, G., Giudice, S., and Ganci, C. [Comparative abstraction of the ability of acetylcysteine in articulate and intramuscular administering in astute respiratory diseases in pediatrics]. Minerva Pediatr 5-26-1973;25(19):844-849. View abstract.

Beloqui, O., Prieto, J., Suarez, M., Gil, B., Qian, C. H., Garcia, N., and Civeira, M. P. N-acetyl cysteine enhances the acknowledgment to interferon-alpha in abiding hepatitis C: a pilot study. J.Interferon Res. 1993;13(4):279-282. View abstract.

[caption id="" align="aligncenter" width="1600"]nursing care plan - Nursing Care Plan Examples | epistaxis care plan
[/caption]

Berk, M., Copolov, D. L., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., and Bush, A. I. N-acetyl cysteine for depressive affection in bipolar disorder--a double-blind randomized placebo-controlled trial. Biol Psychiatry 9-15-2008;64(6):468-475. View abstract.

Berk, M., Copolov, D., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., Judd, F., Katz, F., Katz, P., Ording-Jespersen, S., Little, J., Conus, P., Cuenod, M., Do, K. Q., and Bush, A. I. N-acetyl cysteine as a glutathione forerunner for schizophrenia--a double-blind, randomized, placebo-controlled trial. Biol Psychiatry 9-1-2008;64(5):361-368. View abstract.

Bernard, G. R., Wheeler, A. P., Arons, M. M., Morris, P. E., Paz, H. L., Russell, J. A., and Wright, P. E. A balloon of antioxidants N-acetylcysteine and procysteine in ARDS. The Antioxidant in ARDS Abstraction Group. Chest 1997;112(1):164-172. View abstract.

BERNSTEIN, I. L. and AUSDENMOORE, R. W. IATROGENIC BRONCHOSPASM OCCURRING DURING CLINICAL TRIALS OF A NEW MUCOLYTIC AGENT, ACETYLCYSTEINE. Dis.Chest 1964;46:469-473. View abstract.

Bibi, H., Seifert, B., Oullette, M., and Belik, J. Intratracheal N-acetylcysteine use in breed with abiding lung disease. Acta Paediatr. 1992;81(4):335-339. View abstract.

Bijlmer-Iest, J. C., Baart, de la Faille, van Asbeck, B. S., van, Hattum J., van, Weelden H., Marx, J. J., and Koningsberger, J. C. Protoporphyrin photosensitivity cannot be attenuated by articulate N-acetylcysteine. Photodermatol.Photoimmunol.Photomed. 1992;9(6):245-249. View abstract.

Binet, H., Simonart, T., Van Vooren, J. P., Heenen, M., Liesnard, C., Delforge, M. L., Farber, C. M., and Parent, D. Porphyria cutanea tarda in a animal immunodeficiency virus-infected patient: assay with N-acetyl-cysteine. Int.J.Dermatol. 1998;37(9):718-719. View abstract.

Biscatti, G., Bruschelli, M., Damonte, G., and Capozzi, F. [Controlled studies of the analytic furnishings of acetylcysteine in articulate administering in respiratory infections in pediatrics]. Minerva Pediatr 7-28-1972;24(26):1075-1084. View abstract.

Block, K. I., Koch, A. C., Mead, M. N., Tothy, P. K., Newman, R. A., and Gyllenhaal, C. Impact of antioxidant supplementation on chemotherapeutic toxicity: a analytical assay of the affirmation from randomized controlled trials. Int.J Blight 9-15-2008;123(6):1227-1239. View abstract.

Boesgaard, S., Aldershvile, J., and Poulsen, H. E. Antitoxin administering of intravenous N-acetylcysteine and development of altruism to isosorbide dinitrate in patients with angina pectoris. Apportionment 1992;85(1):143-149. View abstract.

Boman, G., Backer, U., Larsson, S., Melander, B., and Wahlander, L. Articulate acetylcysteine reduces deepening amount in abiding bronchitis: address of a balloon organized by the Swedish Society for Pulmonary Diseases. Eur J Respir.Dis 1983;64(6):405-415. View abstract.

Boogaard, R., de Jongste, J. C., and Merkus, P. J. Pharmacotherapy of broken mucociliary approval in non-CF pediatric lung disease. A assay of the literature. Pediatr Pulmonol. 2007;42(11):989-1001. View abstract.

Borgstrom, L., Kagedal, B., and Paulsen, O. Pharmacokinetics of N-acetylcysteine in man. Eur.J Clin Pharmacol 1986;31(2):217-222. View abstract.

Bowles, W. H. and Goral, V. Analytic balloon of the anti-plaque action of a mucolytic agent, N-Acetyl Cysteine. Dent.Hyg.(Chic.) 1985;59(10):454-456. View abstract.

Braganza, J. M., Holmes, A. M., Morton, A. R., Stalley, L., Ku, R., and Kisher, R. Acetylcysteine to amusement complications of pancreatitis. Lancet 4-19-1986;1(8486):914-915. View abstract.

Braum, D. Randomisierte Vergleichsstudie Sinupret Dragées vs. Fluimucil Granulat bei akuter und chronischer Sinusitis. 1986;

Bridgeman, M. M., Marsden, M., MacNee, W., Flenley, D. C., and Ryle, A. P. Cysteine and glutathione concentrations in claret and bronchoalveolar lavage aqueous afterwards assay with N-acetylcysteine. Thorax 1991;46(1):39-42. View abstract.

Bridgeman, M. M., Marsden, M., Selby, C., Morrison, D., and MacNee, W. Aftereffect of N-acetyl cysteine on the concentrations of thiols in plasma, bronchoalveolar lavage fluid, and lung tissue. Thorax 1994;49(7):670-675. View abstract.

Briguori, C., Manganelli, F., Scarpato, P., Elia, P. P., Golia, B., Riviezzo, G., Lepore, S., Librera, M., Villari, B., Colombo, A., and Ricciardelli, B. Acetylcysteine and adverse agent-associated nephrotoxicity. J Am Coll.Cardiol. 7-17-2002;40(2):298-303. View abstract.

Brocard, H., Charpin, J., and Germouty, J. [Multicenter, double-blind abstraction of articulate acetylcysteine vs. placebo]. Eur.J Respir.Dis.Suppl 1980;111:65-69. View abstract.

Brok, J., Buckley, N., and Gluud, C. Interventions for paracetamol (acetaminophen) overdose. Cochrane Database.Syst.Rev. 2006;(2):CD003328. View abstract.

Buckley, N. A., Whyte, I. M., O'Connell, D. L., and Dawson, A. H. Activated charcoal reduces the charge for N-acetylcysteine assay afterwards acetaminophen (paracetamol) overdose. J Toxicol.Clin Toxicol. 1999;37(6):753-757. View abstract.

Buckley, N. A., Whyte, I. M., O'Connell, D. L., and Dawson, A. H. Articulate or intravenous N-acetylcysteine: which is the assay of best for acetaminophen (paracetamol) poisoning? J Toxicol.Clin Toxicol. 1999;37(6):759-767. View abstract.

Burgunder, J. M., Varriale, A., and Lauterburg, B. H. Aftereffect of N-acetylcysteine on claret cysteine and glutathione afterward paracetamol administration. Eur.J Clin Pharmacol 1989;36(2):127-131. View abstract.

Burkhart, K. K., Janco, N., Kulig, K. W., and Rumack, B. H. Cimetidine as accessory assay for acetaminophen overdose. Hum Exp.Toxicol. 1995;14(3):299-304. View abstract.

Burns, K. E., Chu, M. W., Novick, R. J., Fox, S. A., Gallo, K., Martin, C. M., Stitt, L. W., Heidenheim, A. P., Myers, M. L., and Moist, L. Perioperative N-acetylcysteine to anticipate renal dysfunction in high-risk patients ability cabg surgery: a randomized controlled trial. JAMA 7-20-2005;294(3):342-350. View abstract.

Carbonell, N., Blasco, M., Sanjuan, R., Perez-Sancho, E., Sanchis, J., Insa, L., Bodi, V., Nunez, J., Garcia-Ramon, R., and Miguel, A. Intravenous N-acetylcysteine for preventing contrast-induced nephropathy: a randomised trial. Int J Cardiol. 1-31-2007;115(1):57-62. View abstract.

Casola, G. and vanSonnenberg, E. Skin accident from acetylcysteine aperture during percutaneous abscess drainage. Radiology 1984;152(1):233. View abstract.

Cato, A., Goldstein, I., and Millman, M. A double-blind alongside abstraction of acetylcysteine-isoproterenol and saline-isoproterenol in patients with abiding adverse lung disease. J Int Med Res 1977;5(3):175-183. View abstract.

Chan, A., Paskavitz, J., Remington, R., Rasmussen, S., and Shea, T. B. Ability of a vitamin/nutriceutical conception for early-stage Alzheimer's disease: a 1-year, open-label pilot abstraction with an 16-month caregiver extension. Am.J Alzheimers.Dis Added Demen. 12-20-2008;23(6):571-585. View abstract.

Chan, T. Y. and Critchley, J. A. Adverse reactions to intravenous N-acetylcysteine in Chinese patients with paracetamol (acetaminophen) poisoning. Hum Exp.Toxicol. 1994;13(8):542-544. View abstract.

Charley, G., Dean, B. S., and Krenzelok, E. P. Articulate N-acetylcysteine-induced urticaria: a case report. Vet.Hum Toxicol. 1987;29:477.

Charunwatthana, P., Abul, Faiz M., Ruangveerayut, R., Maude, R. J., Rahman, M. R., Roberts, L. J., Moore, K., Bin, Yunus E., Hoque, M. G., Hasan, M. U., Lee, S. J., Pukrittayakamee, S., Newton, P. N., White, N. J., Day, N. P., and Dondorp, A. M. N-acetylcysteine as accessory assay in astringent malaria: a randomized, double-blinded placebo-controlled analytic trial. Crit Affliction Med 2009;37(2):516-522. View abstract.

Chen, N., Aleksa, K., Woodland, C., Rieder, M., and Koren, G. Blockage of ifosfamide nephrotoxicity by N-acetylcysteine: analytic pharmacokinetic considerations. Can J Clin Pharmacol 2007;14(2):e246-e250. View abstract.

Chen, P., Bauer, G., Mitchell, J., Factor, R., Markham, R., and Schwartz, D. H. N-acetyl-cysteine and L-2-oxothiazolidine-4-carboxylic acerbic enhance contact-dependent advance of HIV in comatose borderline claret mononuclear beef (PBMC) in vitro and access accretion of HIV from human-PBMC SCID mice. AIDS 1997;11(1):33-41. View abstract.

Chirkov, Y. Y. and Horowitz, J. D. N-Acetylcysteine potentiates nitroglycerin-induced changeabout of platelet aggregation. J Cardiovasc.Pharmacol 1996;28(3):375-380. View abstract.

Chodosh, S. and Medici, T. C. The bronchial epithelium in abiding bronchitis. I. Exfoliative assay during stable, astute bacterial infection and accretion phases. Am Rev.Respir.Dis. 1971;104(6):888-898. View abstract.

Chodosh, S., Baigelman, W., Medici, T. C., and Enslein, K. Abiding home use of acetylcysteine in abiding bronchitis. Curr Ther Res Clin Exp. 1975;17(4):319-334. View abstract.

Chun, L. J., Tong, M. J., Busuttil, R. W., and Hiatt, J. R. Acetaminophen hepatotoxicity and astute alarmist failure. J Clin Gastroenterol. 2009;43(4):342-349. View abstract.

Cimino, L., Belisario, M. A., Intrieri, M., D'Ascoli, B., Sacchetti, L., Salvatore, F., and Budillon, G. Aftereffect of N-acetyl-cysteine on lymphomonocyte glutathione and acknowledgment to interferon assay in C-virus abiding hepatitis. Ital.J.Gastroenterol.Hepatol. 1998;30(2):189-193. View abstract.

Cotgreave, I. A. and Moldeus, P. Methodologies for the assay of bargain and breakable N-acetylcysteine in biological systems. Biopharm.Drug Dispos. 1987;8(4):365-375. View abstract.

Coyle, L. C., Rodriguez, A., Jeschke, R. E., Simon-Lee, A., Abbott, K. C., and Taylor, A. J. Acetylcysteine In Diabetes (AID): a randomized abstraction of acetylcysteine for the blockage of adverse nephropathy in diabetics. Am Affection J 2006;151(5):1032-12. View abstract.

D'Agostini, F., Balansky, R. M., Camoirano, A., and De, Flora S. Interactions amid N-acetylcysteine and ascorbic acerbic in modulating mutagenesis and carcinogenesis. Int J Blight 12-1-2000;88(5):702-707. View abstract.

Dal, Negro R., Visconti, M., Trevisan, F., Bertacco, S., Micheletto, C., and Tognella, S. Erdosteine enhances airway acknowledgment to salbutamol in patients with mild-to-moderate COPD. Ther Adv.Respir.Dis. 2008;2(5):271-277. View abstract.

Dano, G. Bronchospasm acquired by acetylcysteine in accouchement with bronchial asthma. Acta Allergol. 1971;26(3):181-190. View abstract.

Dawson, A. H., Henry, D. A., and McEwen, J. Adverse reactions to N-acetylcysteine during assay for paracetamol poisoning. Med J Aust. 3-20-1989;150(6):329-331. View abstract.

de Boer, W. I., Yao, H., and Rahman, I. Future ameliorative assay of COPD: attempt amid oxidants and cytokines. Int J Chron.Obstruct.Pulmon.Dis. 2007;2(3):205-228. View abstract.

de Gussem, E. M., Snijder, R. J., Disch, F. J., Zanen, P., Westermann, C. J., and Mager, J. J. The aftereffect of N-acetylcysteine on epistaxis and affection of action in patients with HHT: a pilot study. Rhinology 2009;47(1):85-88. View abstract.

De Rosa, S. C., Zaretsky, M. D., Dubs, J. G., Roederer, M., Anderson, M., Green, A., Mitra, D., Watanabe, N., Nakamura, H., Tjioe, I., Deresinski, S. C., Moore, W. A., Ela, S. W., Parks, D., Herzenberg, L. A., and Herzenberg, L. A. N-acetylcysteine replenishes glutathione in HIV infection. Eur.J Clin Invest 2000;30(10):915-929. View abstract.

De, Caro L., Ghizzi, A., Costa, R., Longo, A., Ventresca, G. P., and Lodola, E. Pharmacokinetics and bioavailability of articulate acetylcysteine in advantageous volunteers. Arzneimittelforschung. 1989;39(3):382-386. View abstract.

de, Quay B., Malinverni, R., and Lauterburg, B. H. Glutathione burning in HIV-infected patients: role of cysteine absence and aftereffect of articulate N-acetylcysteine. AIDS 1992;6(8):815-819. View abstract.

Decramer, M., Rutten-van, Molken M., Dekhuijzen, P. N., Troosters, T., van, Herwaarden C., Pellegrino, R., van Schayck, C. P., Olivieri, D., Del, Donno M., De, Backer W., Lankhorst, I., and Ardia, A. Furnishings of N-acetylcysteine on outcomes in abiding adverse pulmonary ache (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomised placebo-controlled trial. Lancet 4-30-2005;365(9470):1552-1560. View abstract.

Dekhuijzen, P. N. and van Beurden, W. J. The role for N-acetylcysteine in the administering of COPD. Int J Chron.Obstruct.Pulmon.Dis. 2006;1(2):99-106. View abstract.

Dekhuijzen, P. N. and Van Herwaarden, C. L. Aftereffect of N-acetyl cysteine on thiol levels. Thorax 1995;50(2):215. View abstract.

Delneste, Y., Jeannin, P., Potier, L., Romero, P., and Bonnefoy, J. Y. N-acetyl-L-cysteine exhibits antitumoral action by accretion bump afterlife agency alpha-dependent T-cell cytotoxicity. Claret 8-1-1997;90(3):1124-1132. View abstract.

Denton, R., Kwart, H., and Litt, M. N-acetylcysteine in cystic fibrosis. Mechanical and actinic factors in assay by aerosol. Am Rev.Respir.Dis. 1967;95(4):643-651. View abstract.

di Mario, F., Cavallaro, L. G., Nouvenne, A., Stefani, N., Cavestro, G. M., Iori, V., Maino, M., Comparato, G., Fanigliulo, L., Morana, E., Pilotto, A., Martelli, L., Martelli, M., Leandro, G., and Franze, A. A curcumin-based 1-week amateur assay for abolishment of Helicobacter pylori infection: article to apprentice from failure? Helicobacter. 2007;12(3):238-243. View abstract.

Diaz-Sandoval, L. J., Kosowsky, B. D., and Losordo, D. W. Acetylcysteine to anticipate angiography-related renal tissue abrasion (the APART trial). Am J Cardiol. 2-1-2002;89(3):356-358. View abstract.

Dietzsch, H. J., Berger, G., Gottschalk, B., Leupold, W., Mittenzwey, K. W., Rupprecht, E., and Wunderlich, P. [Experiences with articulate N-acetyl-cysteine assay in accouchement adversity from cystic fibrosis (author's transl)]. Z.Erkr.Atmungsorgane. 1980;155(1):109-113. View abstract.

DiMari, J., Megyesi, J., Udvarhelyi, N., Price, P., Davis, R., and Safirstein, R. N-acetyl cysteine ameliorates ischemic renal failure. Am J Physiol 1997;272(3 Pt 2):F292-F298. View abstract.

Dorsch, W., Auch, E., and Powerlowicz, P. Adverse furnishings of acetylcysteine on animal and guinea pig bronchial asthma in vivo and on animal fibroblasts and leukocytes in vitro. Int Arch Allergy Appl Immunol. 1987;82(1):33-39. View abstract.

Duijvestijn, Y. C. and Brand, P. L. Analytical assay of N-acetylcysteine in cystic fibrosis. Acta Paediatr. 1999;88(1):38-41. View abstract.

Durham, J. D., Caputo, C., Dokko, J., Zaharakis, T., Pahlavan, M., Keltz, J., Dutka, P., Marzo, K., Maesaka, J. K., and Fishbane, S. A randomized controlled balloon of N-acetylcysteine to anticipate adverse nephropathy in cardiac angiography. Branch Int 2002;62(6):2202-2207. View abstract.

Efrati, S., Dishy, V., Averbukh, M., Blatt, A., Krakover, R., Weisgarten, J., Morrow, J. D., Stein, M. C., and Golik, A. The aftereffect of N-acetylcysteine on renal function, nitric oxide, and oxidative accent afterwards angiography. Branch Int 2003;64(6):2182-2187. View abstract.

Ege, T., Eskiocak, S., Edis, M., and Duran, E. The role of N-acetylcysteine in lower acme ischemia/reperfusions. J Cardiovasc.Surg (Torino) 2006;47(5):563-568. View abstract.

Eklund, A., Eriksson, O., Hakansson, L., Larsson, K., Ohlsson, K., Venge, P., Bergstrand, H., Bjornson, A., Brattsand, R., Glennow, C., and . Articulate N-acetylcysteine reduces called humoral markers of anarchic corpuscle action in BAL aqueous from advantageous smokers: alternation to furnishings on cellular variables. Eur.Respir.J 1988;1(9):832-838. View abstract.

El, Mahmoud R., Le, Feuvre C., Le Quan Sang, K. H., Helft, G., Beygui, F., Batisse, J. P., and Metzger, J. P. [Absence of nephro-protective aftereffect of acetylcysteine in patients with abiding renal abortion advised by coronary angiography]. Arch Mal Coeur Vaiss. 2003;96(12):1157-1161. View abstract.

El-Hamamsy, I., Stevens, L. M., Carrier, M., Pellerin, M., Bouchard, D., Demers, P., Cartier, R., Page, P., and Perrault, L. P. Aftereffect of intravenous N-acetylcysteine on outcomes afterwards coronary avenue bypass surgery: a randomized, double-blind, placebo-controlled analytic trial. J Thorac.Cardiovasc.Surg 2007;133(1):7-12. View abstract.

Elnashar, A., Fahmy, M., Mansour, A., and Ibrahim, K. N-acetyl cysteine vs. metformin in assay of clomiphene citrate-resistant polycystic ovary syndrome: a -to-be randomized controlled study. Fertil.Steril. 2007;88(2):406-409. View abstract.

Endo, A. and Watanabe, T. Assay of careful action of N-acetylcysteine adjoin teratogenicity of abundant metals. Reprod.Toxicol. 1988;2(2):141-144. View abstract.

Eren, N., Cakir, O., Oruc, A., Kaya, Z., and Erdinc, L. Furnishings of N-acetylcysteine on pulmonary action in patients ability coronary avenue bypass anaplasty with cardiopulmonary bypass. Perfusion 2003;18(6):345-350. View abstract.

Erley, C. [Iodinated adverse agent-induced nephropathy]. Radiologe 2007;47(9):761-767. View abstract.

Eylar, E. H., Baez, I., Vazquez, A., and Yamamura, Y. N-acetylcysteine (NAC) enhances interleukin-2 but suppresses interleukin-4 beard from accustomed and HIV CD4 T-cells. Corpuscle Mol.Biol (Noisy.-le-grand) 1995;41 Suppl 1:S35-S40. View abstract.

Ferreira, L. F. and Reid, M. B. Muscle-derived ROS and thiol adjustment in beef fatigue. J Appl Physiol 2008;104(3):853-860. View abstract.

Fischer, U. M., Tossios, P., and Mehlhorn, U. Renal aegis by abolitionist scavenging in cardiac anaplasty patients. Curr Med Res Opin. 2005;21(8):1161-1164. View abstract.

Fishbane, S. N-acetylcysteine in the blockage of contrast-induced nephropathy. Clin J Am Soc Nephrol. 2008;3(1):281-287. View abstract.

Flescher, E. and Fingrut, O. Abolishment of interleukin 2 biosynthesis by three modes of oxidative cellular stress: careful blockage by N-acetyl cysteine. Cytokine 2000;12(5):495-498. View abstract.

Forman, M. B., Puett, D. W., Cates, C. U., McCroskey, D. E., Beckman, J. K., Greene, H. L., and Virmani, R. Glutathione redox alleyway and reperfusion injury. Aftereffect of N-acetylcysteine on barricade admeasurement and ventricular function. Apportionment 1988;78(1):202-213. View abstract.

Foschino Barbaro, M. P., Serviddio, G., Resta, O., Rollo, T., Tamborra, R., Elisiana, Carpagnano G., Vendemiale, G., and Altomare, E. Oxygen assay at low breeze causes oxidative accent in abiding adverse pulmonary disease: Blockage by N-acetyl cysteine. Free Radic.Res 2005;39(10):1111-1118. View abstract.

Fulghesu, A. M., Ciampelli, M., Muzj, G., Belosi, C., Selvaggi, L., Ayala, G. F., and Lanzone, A. N-acetyl-cysteine assay improves insulin acuteness in women with polycystic ovary syndrome. Fertil.Steril. 2002;77(6):1128-1135. View abstract.

Fung, J. W. S. C., Chan, W., Kum, W., and et al. Can N-acetylcysteine absolutely anticipate contrast-induced nephropathy in patients with abiding renal insufficiency? A randomized abstraction and affiliated analysis. Eur Affection J 2003;24(S136) View abstract.

Fung, J. W., Szeto, C. C., Chan, W. W., Kum, L. C., Chan, A. K., Wong, J. T., Wu, E. B., Yip, G. W., Chan, J. Y., Yu, C. M., Woo, K. S., and Sanderson, J. E. Aftereffect of N-acetylcysteine for blockage of adverse nephropathy in patients with abstinent to astringent renal insufficiency: a randomized trial. Am.J Branch Dis. 2004;43(5):801-808. View abstract.

Gass, J. T. and Olive, M. F. Glutamatergic substrates of biologic addiction and alcoholism. Biochem.Pharmacol 1-1-2008;75(1):218-265. View abstract.

Gavish, D. and Breslow, J. L. Lipoprotein(a) abridgement by N-acetylcysteine. Lancet 1-26-1991;337(8735):203-204. View abstract.

Gawenda, M., Moller, A., Wassmer, G., and Brunkwall, J. [Prophylaxis of contrast-induced nephropathy with N-acetylcysteine]. Zentralbl.Chir 2007;132(3):227-231. View abstract.

Gepts, L. Articulate acetylcysteine assay in deepening of abiding bronchitis in 49 patients. Eur J Respir.Dis 1980;61(Suppl 111):109.

Gervais, S., Lussier-Labelle, F., and Beaudet, G. Anaphylactoid acknowledgment to acetylcysteine. Clin Pharm 1984;3(6):586-587. View abstract.

Ghanei, M., Shohrati, M., Jafari, M., Ghaderi, S., Alaeddini, F., and Aslani, J. N-acetylcysteine improves the analytic altitude of alacrity gas-exposed patients with accustomed pulmonary action test. Basic Clin Pharmacol Toxicol. 2008;103(5):428-432. View abstract.

Girardi, G. and Elias, M. M. Effectiveness of N-acetylcysteine in attention adjoin mercuric chloride-induced nephrotoxicity. Toxicology 4-8-1991;67(2):155-164. View abstract.

Glantzounis, G. K., Yang, W., Koti, R. S., Mikhailidis, D. P., Seifalian, A. M., and Davidson, B. R. The role of thiols in alarmist ischemia-reperfusion injury. Curr Pharm Des 2006;12(23):2891-2901. View abstract.

Goldenberg, I. J. M., Matetzki, S., Schechter, M, and et al. Contrast-associated nephropathy and analytic aftereffect of patients with abiding renal dearth ability cardiac catheterization: abridgement of accretion account of acetylcysteine to acrid hydration. J Am Coll.Cardiol. 2003;41:537A.

Goldenberg, I., Shechter, M., Matetzky, S., Jonas, M., Adam, M., Pres, H., Elian, D., Agranat, O., Schwammenthal, E., and Guetta, V. Articulate acetylcysteine as an accessory to acrid hydration for the blockage of contrast-induced nephropathy afterward coronary angiography. A randomized controlled balloon and assay of the accepted literature. Eur.Heart J 2004;25(3):212-218. View abstract.

Gomes, V. O., Caramori, P., Lasevitch, R., Brizolara, A., Nery, P., Araujo, A., Hemesath, M., and Brito, F. S. Jr. Blockage of contrast-induced nephropathy with N-acetylcysteine in patients ability coronary angiography: a randomized multicenter trial. Apportionment 2003;108:IV-460.

Gon, Y., Hashimoto, S., Nakayama, T., Matsumoto, K., Koura, T., Takeshita, I., and Horie, T. N-acetyl-L-cysteine inhibits bleomycin-induced interleukin-8 beard by bronchial epithelial cells. Respirology. 2000;5(4):309-313. View abstract.

Gonzales, D. A., Norsworthy, K. J., Kern, S. J., Banks, S., Sieving, P. C., Star, R. A., Natanson, C., and Danner, R. L. A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised absorption to boldness heterogeneity. BMC.Med 2007;5:32. View abstract.

Gottschalk, B. [Therapy of mucoviscidosis application aerosols]. Dtsch.Gesundheitsw. 6-15-1972;27(24):1121-1124. View abstract.

Gotz, M., Kraemer, R., Kerrebijn, K. F., and Popow, C. Articulate acetylcysteine in cystic fibrosis. A branch study. Eur.J Respir.Dis.Suppl 1980;111:122-126. View abstract.

Grant, J. E., Kim, S. W., and Odlaug, B. L. N-acetyl cysteine, a glutamate-modulating agent, in the assay of dissection gambling: a pilot study. Biol Psychiatry 9-15-2007;62(6):652-657. View abstract.

Grant, P. R., Black, A., Garcia, N., Prieto, J., and Garson, J. A. Aggregate assay with interferon-alpha additional N-acetyl cysteine for abiding hepatitis C: a placebo controlled double-blind multicentre study. J.Med.Virol. 2000;61(4):439-442. View abstract.

Grassi, C. and Morandini, G. C. A controlled balloon of alternate articulate acetylcysteine in the abiding assay of abiding bronchitis. Eur.J Clin Pharmacol 3-22-1976;09(5-6):393-396. View abstract.

Grassi, C., Morandini, G. C., and Frigerio, G. Analytic appraisal of systemic acetylcysteine by altered routes of administration. Curr Ther Res Clin Exp. 1973;15(4):165-179. View abstract.

Grater, W. C. and Cato, A. Double-blind abstraction of acetylcysteine-isoproterenol and saline-isoproterenol in non-hospitalized patients with asthma. Curr Ther Res Clin Exp. 1973;15(9):660-671. View abstract.

Grimble, G. K. Adverse gastrointestinal furnishings of arginine and accompanying amino acids. J Nutr 2007;137(6 Suppl 2):1693S-1701S. View abstract.

Guijarro, L. G., Mate, J., Gisbert, J. P., Perez-Calle, J. L., Marin-Jimenez, I., Arriaza, E., Olleros, T., Delgado, M., Castillejo, M. S., Prieto-Merino, D., Gonzalez, Lara, V, and Pena, A. S. N-acetyl-L-cysteine accumulated with mesalamine in the assay of ulcerative colitis: randomized, placebo-controlled pilot study. World J Gastroenterol. 5-14-2008;14(18):2851-2857. View abstract.

Gunduz, H., Karabay, O., Tamer, A., Ozaras, R., Mert, A., and Tabak, O. F. N-acetyl cysteine assay in astute viral hepatitis. World J.Gastroenterol. 2003;9(12):2698-2700. View abstract.

Gurbuz, A. K., Ozel, A. M., Ozturk, R., Yildirim, S., Yazgan, Y., and Demirturk, L. Aftereffect of N-acetyl cysteine on Helicobacter pylori. South.Med J 2005;98(11):1095-1097. View abstract.

Gurtoo, H. L., Marinello, A. J., Berrigan, M. J., Bansal, S. K., Paul, B., Pavelic, Z. P., and Struck, R. F. Aftereffect of thiols on toxicity and carcinostatic action of cyclophosphamide. Semin.Oncol 1983;10(1 Suppl 1):35-45. View abstract.

Haase, M., Haase-Fielitz, A., Bagshaw, S. M., Reade, M. C., Morgera, S., Seevenayagam, S., Matalanis, G., Buxton, B., Doolan, L., and Bellomo, R. Appearance II, randomized, controlled balloon of high-dose N-acetylcysteine in high-risk cardiac anaplasty patients. Crit Affliction Med 2007;35(5):1324-1331. View abstract.

Hansen, N. C., Skriver, A., Brorsen-Riis, L., Balslov, S., Evald, T., Maltbaek, N., Gunnersen, G., Garsdal, P., Sander, P., Pedersen, J. Z., and . Orally administered N-acetylcysteine may advance accepted abundance in patients with balmy abiding bronchitis. Respir.Med 1994;88(7):531-535. View abstract.

Harrison, P. M., Keays, R., Bray, G. P., Alexander, G. J., and Williams, R. Improved aftereffect of paracetamol-induced atomic hepatic abortion by backward administering of acetylcysteine. Lancet 6-30-1990;335(8705):1572-1573. View abstract.

Harrison, P. M., Wendon, J. A., Gimson, A. E., Alexander, G. J., and Williams, R. Advance by acetylcysteine of hemodynamics and oxygen carriage in atomic hepatic failure. N.Engl.J Med 6-27-1991;324(26):1852-1857. View abstract.

Hart, A. M., Terenghi, G., and Wiberg, M. Neuronal afterlife afterwards borderline assumption abrasion and beginning strategies for neuroprotection. Neurol.Res. 2008;30(10):999-1011. View abstract.

Heng, A. E., Cellarier, E., Aublet-Cuvelier, B., Decalf, V., Motreff, P., Marcaggi, X., Deteix, P., and Souweine, B. Is assay with N-acetylcysteine to anticipate contrast-induced nephropathy back application bicarbonate hydration out of date? Clin Nephrol. 2008;70(6):475-484. View abstract.

Henke, M. O. and Ratjen, F. Mucolytics in cystic fibrosis. Paediatr.Respir.Rev. 2007;8(1):24-29. View abstract.

Henneghien, C., Remacle, P., and Bruart, J. Abstraction of the Nacetylcysteine (NAC) by articulate or intravenous administering in abiding bronchitis. Curr Ther Res 1983;34:750-756.

Hershkovitz, E., Shorer, Z., Levitas, A., and Tal, A. Cachet epilepticus afterward intravenous N-acetylcysteine therapy. Isr.J Med Sci 1996;32(11):1102-1104. View abstract.

Hida, W., Shindoh, C., Satoh, J., Sagara, M., Kikuchi, Y., Toyota, T., and Shirato, K. N-acetylcysteine inhibits accident of diaphragm action in streptozotocin-treated rats. Am J Respir.Crit Affliction Med 1996;153(6 Pt 1):1875-1879. View abstract.

Hirsch, S. R. and Kory, R. C. An appraisal of the aftereffect of nebulized N-acetylcysteine on sputum consistency. J Allergy 1967;39(5):265-273. View abstract.

Ho, K. M. and Morgan, D. J. Meta-analysis of N-acetylcysteine to anticipate astute renal abortion afterwards above surgery. Am J Branch Dis. 2009;53(1):33-40. View abstract.

Ho, S. W. and Beilin, L. J. Asthma associated with N-acetylcysteine beverage and paracetamol poisoning: address of two cases. Br Med J (Clin Res Ed) 9-24-1983;287(6396):876-877. View abstract.

Holdiness, M. R. Analytic pharmacokinetics of N-acetylcysteine. Clin Pharmacokinet. 1991;20(2):123-134. View abstract.

Horl, W. H. [Contrast induced nephropathy]. Wien.Klin.Wochenschr. 2009;121(1-2):15-32. View abstract.

Horowitz, J. D., Henry, C. A., Syrjanen, M. L., Louis, W. J., Fish, R. D., Smith, T. W., and Antman, E. M. Accumulated use of nitroglycerin and N-acetylcysteine in the administering of ambiguous angina pectoris. Apportionment 1988;77(4):787-794. View abstract.

Hoshino, Y. and Mishima, M. Redox-based analysis for lung diseases. Antioxid.Redox.Signal. 2008;10(4):701-704. View abstract.

Howatt, W. F. and DeMuth, G. R. A double-blind abstraction of the use of acetylcysteine in patients with cystic fibrosis. Univ Mich.Med Cent.J 1966;32(2):82-85. View abstract.

The Ten Reasons Tourists Love Epistaxis Care Plan. | epistaxis care plan - epistaxis care plan
| Welcome to help my personal website, in this time I'm going to teach you with regards to keyword. And after this, this is actually the first picture:

[caption id="" align="aligncenter" width="1600"]pain nursing care plan - Nursing Care Plan Examples | epistaxis care plan
[/caption]

Why not consider image earlier mentioned? is usually that incredible???. if you're more dedicated thus, I'l d explain to you some graphic yet again beneath:

So, if you like to acquire the amazing images about (The Ten Reasons Tourists Love Epistaxis Care Plan. | epistaxis care plan), click on save button to store the pictures in your personal pc. There're ready for transfer, if you'd rather and want to take it, simply click save logo in the post, and it will be immediately downloaded to your computer.} Lastly if you want to find new and the recent photo related to (The Ten Reasons Tourists Love Epistaxis Care Plan. | epistaxis care plan), please follow us on google plus or bookmark the site, we try our best to provide regular update with all new and fresh images. Hope you like staying right here. For most updates and recent information about (The Ten Reasons Tourists Love Epistaxis Care Plan. | epistaxis care plan) photos, please kindly follow us on twitter, path, Instagram and google plus, or you mark this page on book mark area, We try to offer you up-date regularly with all new and fresh pics, love your surfing, and find the perfect for you.

Thanks for visiting our website, articleabove (The Ten Reasons Tourists Love Epistaxis Care Plan. | epistaxis care plan) published .  At this time we're pleased to declare we have discovered an extremelyinteresting contentto be reviewed, that is (The Ten Reasons Tourists Love Epistaxis Care Plan. | epistaxis care plan) Most people trying to find information about(The Ten Reasons Tourists Love Epistaxis Care Plan. | epistaxis care plan) and certainly one of these is you, is not it?[caption id="" align="aligncenter" width="819"]Acute pain nursing care plan - Nursing Care Plan Examples | epistaxis care plan
[/caption]
[caption id="" align="aligncenter" width="1600"]Acute pain nursing care plan - Nursing Care Plan Examples | epistaxis care plan
[/caption]
[caption id="" align="aligncenter" width="228"]Care Plan for Epistaxis | epistaxis care plan
[/caption]
[caption id="" align="aligncenter" width="1600"]nursing care plan - Nursing Care Plan Examples | epistaxis care plan
[/caption]
[caption id="" align="aligncenter" width="1600"]Asthma nursing care plan - Nursing Care Plan Examples | Nanda ... | epistaxis care plan
[/caption]
[caption id="" align="aligncenter" width="1236"]nursing care plan - Nursing Care Plan Examples | epistaxis care plan
[/caption]
[caption id="" align="aligncenter" width="638"]157934702 case-study-dengue-fever | epistaxis care plan
[/caption]
[caption id="" align="aligncenter" width="1600"]Blank nursing care plans - Nursing Care Plan Examples | epistaxis care plan
[/caption]

Share on Facebook

Share on Twitter

Share on Google+

Share on LinkedIn